{"distance": [[[1, "positive regulation of cell-substrate adhesion (GO:0010811)", 0.0007791063560372328, 58.588235294117645, 419.3372670889321, ["CDH13", "OLFM4"], 0.03649187799249512, 0, 0], [2, "regulation of vesicle-mediated transport (GO:0060627)", 0.0014584201472092786, 42.327659574468086, 276.41661242727787, ["CDH13", "OLFM4"], 0.03649187799249512, 0, 0], [3, "defense response to symbiont (GO:0140546)", 0.0024163697244848196, 32.5672131147541, 196.23338369839547, ["IFNL2", "IFNL1"], 0.03649187799249512, 0, 0], [4, "defense response to virus (GO:0051607)", 0.0027730648199082307, 30.316030534351146, 178.4947893730614, ["IFNL2", "IFNL1"], 0.03649187799249512, 0, 0], [5, "negative regulation of interleukin-13 production (GO:0032696)", 0.002996653029893649, 454.1818181818182, 2638.914119276588, ["IFNL1"], 0.03649187799249512, 0, 0], [6, "negative regulation of interleukin-5 production (GO:0032714)", 0.002996653029893649, 454.1818181818182, 2638.914119276588, ["IFNL1"], 0.03649187799249512, 0, 0], [7, "negative regulation of blood coagulation, intrinsic pathway (GO:2000267)", 0.002996653029893649, 454.1818181818182, 2638.914119276588, ["A2M"], 0.03649187799249512, 0, 0], [8, "positive regulation of MHC class I biosynthetic process (GO:0045345)", 0.002996653029893649, 454.1818181818182, 2638.914119276588, ["IFNL1"], 0.03649187799249512, 0, 0], [9, "regulation of blood coagulation, intrinsic pathway (GO:2000266)", 0.002996653029893649, 454.1818181818182, 2638.914119276588, ["A2M"], 0.03649187799249512, 0, 0], [10, "regulation of neutrophil extravasation (GO:2000389)", 0.0035949984464796287, 363.3272727272727, 2044.8828145385057, ["OLFM4"], 0.03649187799249512, 0, 0], [11, "regulation of type 2 immune response (GO:0002828)", 0.0035949984464796287, 363.3272727272727, 2044.8828145385057, ["IFNL1"], 0.03649187799249512, 0, 0], [12, "keratinocyte proliferation (GO:0043616)", 0.0041930151049605156, 302.75757575757575, 1657.3964565725007, ["CDH13"], 0.03649187799249512, 0, 0], [13, "negative regulation of lymphocyte differentiation (GO:0045620)", 0.0041930151049605156, 302.75757575757575, 1657.3964565725007, ["IFNL1"], 0.03649187799249512, 0, 0], [14, "regulation of necrotic cell death (GO:0010939)", 0.0041930151049605156, 302.75757575757575, 1657.3964565725007, ["OLFM4"], 0.03649187799249512, 0, 0], [15, "negative regulation of type 2 immune response (GO:0002829)", 0.0041930151049605156, 302.75757575757575, 1657.3964565725007, ["IFNL1"], 0.03649187799249512, 0, 0], [16, "regulation of MHC class I biosynthetic process (GO:0045343)", 0.0041930151049605156, 302.75757575757575, 1657.3964565725007, ["IFNL1"], 0.03649187799249512, 0, 0], [17, "sequestering of BMP from receptor via BMP binding (GO:0038098)", 0.00479070309341298, 259.4935064935065, 1385.975083259077, ["CHRDL1"], 0.03649187799249512, 0, 0], [18, "regulation of positive chemotaxis (GO:0050926)", 0.00479070309341298, 259.4935064935065, 1385.975083259077, ["CDH13"], 0.03649187799249512, 0, 0], [19, "positive regulation of endocytic recycling (GO:2001137)", 0.00479070309341298, 259.4935064935065, 1385.975083259077, ["PLA2G4E"], 0.03649187799249512, 0, 0], [20, "regulation of cellular extravasation (GO:0002691)", 0.0053880625223818295, 227.04545454545453, 1185.9876925180256, ["OLFM4"], 0.03649187799249512, 0, 0], [21, "negative regulation of protein activation cascade (GO:2000258)", 0.0053880625223818295, 227.04545454545453, 1185.9876925180256, ["A2M"], 0.03649187799249512, 0, 0], [22, "N-acylphosphatidylethanolamine metabolic process (GO:0070292)", 0.0053880625223818295, 227.04545454545453, 1185.9876925180256, ["PLA2G4E"], 0.03649187799249512, 0, 0], [23, "regulation of neutrophil migration (GO:1902622)", 0.00598509351248777, 201.8080808080808, 1032.9512945731403, ["OLFM4"], 0.037157455556694904, 0, 0], [24, "regulation of memory T cell differentiation (GO:0043380)", 0.00598509351248777, 201.8080808080808, 1032.9512945731403, ["IFNL1"], 0.037157455556694904, 0, 0], [25, "regulation of endocytic recycling (GO:2001135)", 0.006581796197874835, 181.61818181818182, 912.3494182081016, ["PLA2G4E"], 0.039227505339334015, 0, 0], [26, "negative regulation of complement activation (GO:0045916)", 0.007178170714881846, 165.099173553719, 815.046857216495, ["A2M"], 0.040229691526464245, 0, 0], [27, "positive regulation of calcium-mediated signaling (GO:0050850)", 0.007774217207607984, 151.33333333333334, 735.0172993440868, ["CDH13"], 0.040229691526464245, 0, 0], [28, "regulation of interleukin-5 production (GO:0032674)", 0.007774217207607984, 151.33333333333334, 735.0172993440868, ["IFNL1"], 0.040229691526464245, 0, 0], [29, "sequestering of extracellular ligand from receptor (GO:0035581)", 0.008369935820942226, 139.6853146853147, 668.1300945358273, ["CHRDL1"], 0.040229691526464245, 0, 0], [30, "cellular response to low-density lipoprotein particle stimulus (GO:0071404)", 0.008369935820942226, 139.6853146853147, 668.1300945358273, ["CDH13"], 0.040229691526464245, 0, 0], [31, "negative regulation of T cell differentiation (GO:0045581)", 0.008369935820942226, 139.6853146853147, 668.1300945358273, ["IFNL1"], 0.040229691526464245, 0, 0], [32, "negative regulation of immune effector process (GO:0002698)", 0.00956039001281181, 121.04848484848485, 562.8907982194623, ["IFNL1"], 0.04189700329144, 0, 0], [33, "regulation of interleukin-13 production (GO:0032656)", 0.00956039001281181, 121.04848484848485, 562.8907982194623, ["IFNL1"], 0.04189700329144, 0, 0], [34, "regulation of ERBB signaling pathway (GO:1901184)", 0.00956039001281181, 121.04848484848485, 562.8907982194623, ["CDH13"], 0.04189700329144, 0, 0], [35, "positive regulation of positive chemotaxis (GO:0050927)", 0.010155125895608219, 113.47727272727273, 520.8353408254836, ["CDH13"], 0.043231821669874985, 0, 0], [36, "hyaluronan catabolic process (GO:0030214)", 0.010749534506708167, 106.79679144385027, 484.0984098875249, ["HYAL4"], 0.04328866598647343, 0, 0], [37, "phosphatidylinositol acyl-chain remodeling (GO:0036149)", 0.010749534506708167, 106.79679144385027, 484.0984098875249, ["PLA2G4E"], 0.04328866598647343, 0, 0], [38, "Rac protein signal transduction (GO:0016601)", 0.011343616002547938, 100.85858585858585, 451.7557080600296, ["CDH13"], 0.04333843036870879, 0, 0], [39, "glycerolipid catabolic process (GO:0046503)", 0.011343616002547938, 100.85858585858585, 451.7557080600296, ["PLA2G4E"], 0.04333843036870879, 0, 0], [40, "positive regulation of immune system process (GO:0002684)", 0.012530798277531565, 90.76363636363637, 397.50531795625653, ["IFNL1"], 0.04667722358380508, 0, 0], [41, "phosphatidylserine acyl-chain remodeling (GO:0036150)", 0.013123899368825872, 86.43722943722943, 374.56020373045595, ["PLA2G4E"], 0.047529870290991975, 0, 0], [42, "innate immune response (GO:0045087)", 0.013572683267541302, 13.125333333333334, 56.43494440563777, ["IFNL2", "IFNL1"], 0.047529870290991975, 0, 0], [43, "hyaluronan metabolic process (GO:0030212)", 0.013716673976595, 82.50413223140495, 353.872030109198, ["HYAL4"], 0.047529870290991975, 0, 0], [44, "phospholipid catabolic process (GO:0009395)", 0.014309122256811026, 78.91304347826087, 335.1324919763037, ["PLA2G4E"], 0.04845589127874643, 0, 0], [45, "lamellipodium assembly (GO:0030032)", 0.015493040473318351, 72.59272727272727, 302.5203442580517, ["CDH13"], 0.05018397892444423, 0, 0], [46, "phosphatidylethanolamine acyl-chain remodeling (GO:0036152)", 0.015493040473318351, 72.59272727272727, 302.5203442580517, ["PLA2G4E"], 0.05018397892444423, 0, 0], [47, "mucosal immune response (GO:0002385)", 0.01667565529767051, 67.20875420875421, 275.1395602176083, ["IFNL2"], 0.050707604884753184, 0, 0], [48, "glycerophospholipid catabolic process (GO:0046475)", 0.01667565529767051, 67.20875420875421, 275.1395602176083, ["PLA2G4E"], 0.050707604884753184, 0, 0], [49, "regulation of calcium-mediated signaling (GO:0050848)", 0.01667565529767051, 67.20875420875421, 275.1395602176083, ["CDH13"], 0.050707604884753184, 0, 0], [50, "lamellipodium organization (GO:0097581)", 0.017266474337105393, 64.8051948051948, 263.043544162992, ["CDH13"], 0.05145409352457407, 0, 0], [51, "phosphatidylcholine acyl-chain remodeling (GO:0036151)", 0.017856968008938604, 62.56739811912226, 251.8563944353508, ["PLA2G4E"], 0.05186081762570235, 0, 0], [52, "aminoglycan catabolic process (GO:0006026)", 0.018447136470887412, 60.47878787878788, 241.48249384895686, ["HYAL4"], 0.05186081762570235, 0, 0], [53, "phosphatidylethanolamine metabolic process (GO:0046337)", 0.018447136470887412, 60.47878787878788, 241.48249384895686, ["PLA2G4E"], 0.05186081762570235, 0, 0], [54, "positive regulation of receptor signaling pathway via STAT (GO:1904894)", 0.019036979887302796, 58.52492668621701, 231.83899894541258, ["IFNL1"], 0.052527963022372524, 0, 0], [55, "positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427)", 0.01962649841488355, 56.69318181818182, 222.85379213708367, ["IFNL1"], 0.053169968433048165, 0, 0], [56, "phosphatidylserine metabolic process (GO:0006658)", 0.020215692219209058, 54.972451790633606, 214.4638136267328, ["PLA2G4E"], 0.053788181083252666, 0, 0], [57, "negative regulation of cell population proliferation (GO:0008285)", 0.02084945120044108, 10.403713527851458, 40.26682052590156, ["IFNL1", "CDH13"], 0.05402665825304592, 0, 0], [58, "calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339)", 0.021393106288118857, 51.82597402597403, 199.25462501506232, ["CDH13"], 0.05402665825304592, 0, 0], [59, "positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)", 0.021393106288118857, 51.82597402597403, 199.25462501506232, ["OLFM4"], 0.05402665825304592, 0, 0], [60, "negative regulation of innate immune response (GO:0045824)", 0.02256922338610946, 49.01965601965602, 185.84175607013447, ["A2M"], 0.05476766031287691, 0, 0], [61, "positive regulation of intracellular transport (GO:0032388)", 0.02315679597121641, 47.72727272727273, 179.71546945510647, ["PLA2G4E"], 0.05476766031287691, 0, 0], [62, "regulation of T cell differentiation (GO:0045580)", 0.02315679597121641, 47.72727272727273, 179.71546945510647, ["IFNL1"], 0.05476766031287691, 0, 0], [63, "endothelial cell migration (GO:0043542)", 0.02315679597121641, 47.72727272727273, 179.71546945510647, ["CDH13"], 0.05476766031287691, 0, 0], [64, "negative regulation of blood coagulation (GO:0030195)", 0.02374404479036207, 46.5011655011655, 173.93405340895535, ["A2M"], 0.05492900806916125, 0, 0], [65, "epithelial cell migration (GO:0010631)", 0.024330970017212364, 45.336363636363636, 168.47016546086343, ["CDH13"], 0.05492900806916125, 0, 0], [66, "visual system development (GO:0150063)", 0.024330970017212364, 45.336363636363636, 168.47016546086343, ["CHRDL1"], 0.05492900806916125, 0, 0], [67, "positive regulation of cell-matrix adhesion (GO:0001954)", 0.026089805695170006, 42.167019027484145, 153.74983290143678, ["CDH13"], 0.05641460301136417, 0, 0], [68, "regulation of receptor signaling pathway via JAK-STAT (GO:0046425)", 0.026675438127783887, 41.20661157024794, 149.33325716982057, ["IFNL1"], 0.05641460301136417, 0, 0], [69, "negative regulation of T cell activation (GO:0050868)", 0.026675438127783887, 41.20661157024794, 149.33325716982057, ["IFNL1"], 0.05641460301136417, 0, 0], [70, "positive regulation of chemotaxis (GO:0050921)", 0.026675438127783887, 41.20661157024794, 149.33325716982057, ["CDH13"], 0.05641460301136417, 0, 0], [71, "positive regulation of response to stimulus (GO:0048584)", 0.02726074776388067, 40.28888888888889, 145.1329634798573, ["IFNL1"], 0.05641460301136417, 0, 0], [72, "positive regulation of smooth muscle cell proliferation (GO:0048661)", 0.02726074776388067, 40.28888888888889, 145.1329634798573, ["CDH13"], 0.05641460301136417, 0, 0], [73, "adherens junction organization (GO:0034332)", 0.029014741507151904, 37.765151515151516, 133.68679532449664, ["CDH13"], 0.05842157411575181, 0, 0], [74, "regulation of smooth muscle cell proliferation (GO:0048660)", 0.029014741507151904, 37.765151515151516, 133.68679532449664, ["CDH13"], 0.05842157411575181, 0, 0], [75, "positive regulation of cell morphogenesis involved in differentiation (GO:0010770)", 0.029598761568907096, 36.99257884972171, 130.2147194065139, ["OLFM4"], 0.05877063520256545, 0, 0], [76, "regulation of substrate adhesion-dependent cell spreading (GO:1900024)", 0.030182459639590885, 36.25090909090909, 126.89610172901739, ["OLFM4"], 0.05877063520256545, 0, 0], [77, "negative regulation of BMP signaling pathway (GO:0030514)", 0.030765835877853052, 35.53832442067736, 123.7213609818225, ["CHRDL1"], 0.05877063520256545, 0, 0], [78, "sprouting angiogenesis (GO:0002040)", 0.030765835877853052, 35.53832442067736, 123.7213609818225, ["CDH13"], 0.05877063520256545, 0, 0], [79, "glycosaminoglycan metabolic process (GO:0030203)", 0.03193162350337226, 34.19382504288165, 117.76895070161899, ["HYAL4"], 0.05935630505096695, 0, 0], [80, "cellular response to cytokine stimulus (GO:0071345)", 0.032604577769221134, 8.128333333333334, 27.825744455648255, ["IFNL2", "IFNL1"], 0.05935630505096695, 0, 0], [81, "glycosaminoglycan catabolic process (GO:0006027)", 0.03309612573679984, 32.94710743801653, 112.2949128878184, ["HYAL4"], 0.05935630505096695, 0, 0], [82, "Rho protein signal transduction (GO:0007266)", 0.03309612573679984, 32.94710743801653, 112.2949128878184, ["CDH13"], 0.05935630505096695, 0, 0], [83, "sensory organ development (GO:0007423)", 0.03309612573679984, 32.94710743801653, 112.2949128878184, ["CHRDL1"], 0.05935630505096695, 0, 0], [84, "positive regulation of interferon-gamma production (GO:0032729)", 0.03367789522880521, 32.357142857142854, 109.72027527854156, ["IFNL1"], 0.05935630505096695, 0, 0], [85, "eye development (GO:0001654)", 0.03425934385492052, 31.78787878787879, 107.24581633848625, ["CHRDL1"], 0.05935630505096695, 0, 0], [86, "regulation of phagocytosis (GO:0050764)", 0.03425934385492052, 31.78787878787879, 107.24581633848625, ["OLFM4"], 0.05935630505096695, 0, 0], [87, "positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)", 0.034840471769761905, 31.238244514106583, 104.86602418496526, ["IFNL1"], 0.05966931372062671, 0, 0], [88, "homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)", 0.035421279144613474, 30.70724191063174, 102.57577696947945, ["CDH13"], 0.059974665824402355, 0, 0], [89, "regulation of endocytosis (GO:0030100)", 0.03600176612865679, 30.193939393939395, 100.37030934492944, ["CDH13"], 0.060272619698537776, 0, 0], [90, "antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)", 0.037741306359582505, 28.751803751803752, 94.21966448632159, ["CXCL14"], 0.06232269598711797, 0, 0], [91, "regulation of cell-matrix adhesion (GO:0001952)", 0.038320513395665175, 28.301136363636363, 92.31179552985674, ["CDH13"], 0.06232269598711797, 0, 0], [92, "extracellular matrix disassembly (GO:0022617)", 0.03889940085101994, 27.864335664335666, 90.46926829385504, ["A2M"], 0.06232269598711797, 0, 0], [93, "cellular component disassembly (GO:0022411)", 0.03889940085101994, 27.864335664335666, 90.46926829385504, ["A2M"], 0.06232269598711797, 0, 0], [94, "regulation of epidermal growth factor receptor signaling pathway (GO:0042058)", 0.039477968873990896, 27.44077134986226, 88.6889163609223, ["CDH13"], 0.06257678044919833, 0, 0], [95, "regulation of tyrosine phosphorylation of STAT protein (GO:0042509)", 0.040056217631282115, 27.029850746268657, 86.96777093294467, ["IFNL1"], 0.0628250150216951, 0, 0], [96, "negative regulation of cell adhesion (GO:0007162)", 0.042942678013426154, 25.146464646464647, 79.15828251915687, ["CDH13"], 0.0666506148333385, 0, 0], [97, "negative regulation of cellular process (GO:0048523)", 0.043734808326550065, 6.887943262411348, 21.556582758480396, ["IFNL1", "CDH13"], 0.06674922034548711, 0, 0], [98, "positive regulation of immune response (GO:0050778)", 0.04409503288389166, 24.464373464373466, 76.36329437117712, ["IFNL1"], 0.06674922034548711, 0, 0], [99, "phospholipid metabolic process (GO:0006644)", 0.04467073326473782, 24.136969696969697, 75.02824312324114, ["PLA2G4E"], 0.06674922034548711, 0, 0], [100, "phosphatidylcholine metabolic process (GO:0046470)", 0.04524611580465905, 23.818181818181817, 73.7324794714548, ["PLA2G4E"], 0.06674922034548711, 0, 0], [101, "positive regulation of endothelial cell proliferation (GO:0001938)", 0.04524611580465905, 23.818181818181817, 73.7324794714548, ["CDH13"], 0.06674922034548711, 0, 0], [102, "glycerophospholipid metabolic process (GO:0006650)", 0.04697035804559035, 22.9102416570771, 70.06498436559322, ["PLA2G4E"], 0.06861356224306825, 0, 0], [103, "cell-cell junction organization (GO:0045216)", 0.04811826663840212, 22.342312008978677, 67.78866163441084, ["CDH13"], 0.06960797795263997, 0, 0], [104, "regulation of interferon-gamma production (GO:0032649)", 0.05041028257884421, 21.28663101604278, 63.595089599609956, ["IFNL1"], 0.07222242407930565, 0, 0], [105, "cytokine-mediated signaling pathway (GO:0019221)", 0.051702535837496774, 6.258158319870759, 18.538219780322443, ["IFNL2", "IFNL1"], 0.073368360378924, 0, 0], [106, "regulation of endothelial cell proliferation (GO:0001936)", 0.05383882244884977, 19.877122877122876, 58.07619178413111, ["CDH13"], 0.07567909947998694, 0, 0], [107, "regulation of cell death (GO:0010941)", 0.059527849199832554, 17.900090009000902, 50.50172123995827, ["OLFM4"], 0.08289392084836496, 0, 0], [108, "phosphatidylinositol metabolic process (GO:0046488)", 0.06518550479553244, 16.27927927927928, 44.450867603715174, ["PLA2G4E"], 0.08993185383828085, 0, 0], [109, "cellular amide metabolic process (GO:0043603)", 0.06687670762493306, 15.848484848484848, 42.86863861107806, ["PLA2G4E"], 0.09141861867995436, 0, 0], [110, "positive regulation of epithelial cell proliferation (GO:0050679)", 0.07137287991941299, 14.80327868852459, 39.07824746413377, ["CDH13"], 0.09667781007265941, 0, 0], [111, "platelet degranulation (GO:0002576)", 0.07249381569444491, 14.563049853372434, 38.21714214339772, ["A2M"], 0.09731151836461524, 0, 0], [112, "regulation of cell population proliferation (GO:0042127)", 0.07465128685434329, 5.046194225721785, 13.094508250641674, ["IFNL1", "CDH13"], 0.09854038156732244, 0, 0], [113, "positive regulation of macromolecule biosynthetic process (GO:0010557)", 0.07473196722890896, 14.105113636363637, 36.58651144234639, ["IFNL1"], 0.09854038156732244, 0, 0], [114, "regulation of cell adhesion (GO:0030155)", 0.07696516706764417, 13.674931129476583, 35.06802532248599, ["CDH13"], 0.10044244763977078, 0, 0], [115, "positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)", 0.0775226944870714, 13.571428571428571, 34.70464751040876, ["IFNL1"], 0.10044244763977078, 0, 0], [116, "regulation of cellular component organization (GO:0051128)", 0.08030570414317773, 13.076416337285902, 32.97760560549118, ["CDH13"], 0.10315129239080588, 0, 0], [117, "regulation of small GTPase mediated signal transduction (GO:0051056)", 0.08141675143721483, 12.888311688311688, 32.32613131615323, ["A2M"], 0.10350678154986107, 0, 0], [118, "Ras protein signal transduction (GO:0007265)", 0.08197181357640004, 12.796260477111542, 32.008307827212725, ["CDH13"], 0.10350678154986107, 0, 0], [119, "cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)", 0.09738928736005688, 10.661108122646585, 24.830137244993452, ["CDH13"], 0.1219412085432645, 0, 0], [120, "negative regulation of immune response (GO:0050777)", 0.10175047824033288, 10.175141242937853, 23.252555875085513, ["IFNL1"], 0.12559692854058374, 0, 0], [121, "regulation of immune response (GO:0050776)", 0.10229426679107169, 10.117466802860061, 23.06682926467287, ["IFNL1"], 0.12559692854058374, 0, 0], [122, "regulated exocytosis (GO:0045055)", 0.10283775357014241, 10.060436769933977, 22.883497050073817, ["A2M"], 0.12559692854058374, 0, 0], [123, "negative regulation of cytokine production (GO:0001818)", 0.10392382237785831, 9.948267202410848, 22.52384317538298, ["IFNL1"], 0.12589145962846252, 0, 0], [124, "regulation of programmed cell death (GO:0043067)", 0.1104149663820142, 9.324069712670749, 20.545677022917864, ["OLFM4"], 0.13267604831387192, 0, 0], [125, "phosphate-containing compound metabolic process (GO:0006796)", 0.12007089711947924, 8.520896165445928, 18.061512696944295, ["PLA2G4E"], 0.14312450936641924, 0, 0], [126, "positive regulation of cell motility (GO:2000147)", 0.1248627470990637, 8.168595041322314, 16.99509010087468, ["CDH13"], 0.14765515331555945, 0, 0], [127, "positive regulation of cell migration (GO:0030335)", 0.15001775039031348, 6.689280868385346, 12.689576884452375, ["CDH13"], 0.17600507722958036, 0, 0], [128, "plasma membrane bounded cell projection assembly (GO:0120031)", 0.15465986057932218, 6.468985887758451, 12.074536959698023, ["CDH13"], 0.18003374395561722, 0, 0], [129, "positive regulation of transcription, DNA-templated (GO:0045893)", 0.15589083664952325, 3.1849280270956815, 5.919504943584241, ["IFNL1", "CDH13"], 0.18005995861068966, 0, 0], [130, "extracellular matrix organization (GO:0030198)", 0.16590957450841412, 5.986318029796291, 10.753297133202047, ["A2M"], 0.19015789693656693, 0, 0], [131, "positive regulation of cytokine production (GO:0001819)", 0.18352431992317214, 5.349482852476864, 9.069556487367386, ["IFNL1"], 0.20874140205002023, 0, 0], [132, "post-translational protein modification (GO:0043687)", 0.18849409594421104, 5.191331923890063, 8.662716368209253, ["CHRDL1"], 0.2127698507249049, 0, 0], [133, "regulation of cell migration (GO:0030334)", 0.21917141641280938, 4.373687737324101, 6.638825567444713, ["CDH13"], 0.245537902597809, 0, 0], [134, "cellular protein metabolic process (GO:0044267)", 0.2234660366325064, 4.2770979020979025, 6.409213404377618, ["CHRDL1"], 0.24848089147942873, 0, 0], [135, "regulation of intracellular signal transduction (GO:1902531)", 0.23293222567035762, 4.076730608840701, 5.939828070057347, ["A2M"], 0.2570881601843206, 0, 0], [136, "negative regulation of nucleic acid-templated transcription (GO:1903507)", 0.24554381708103362, 3.833693304535637, 5.383578322629747, ["IFNL1"], 0.26901491724319126, 0, 0], [137, "positive regulation of cell population proliferation (GO:0008284)", 0.2501663356311247, 3.750720738035749, 5.197108325087597, ["CDH13"], 0.2720787153944349, 0, 0], [138, "neutrophil degranulation (GO:0043312)", 0.25338663554284113, 3.69469696969697, 5.072223180750502, ["OLFM4"], 0.273089598109254, 0, 0], [139, "neutrophil activation involved in immune response (GO:0002283)", 0.2552211099302061, 3.663410969196093, 5.002845647927838, ["OLFM4"], 0.273089598109254, 0, 0], [140, "neutrophil mediated immunity (GO:0002446)", 0.2565942532570172, 3.6402837408997573, 4.951729532081089, ["OLFM4"], 0.273089598109254, 0, 0], [141, "positive regulation of nucleic acid-templated transcription (GO:1903508)", 0.26704483779082666, 3.4720142602495545, 4.584234804758777, ["IFNL1"], 0.28219631794917144, 0, 0], [142, "positive regulation of intracellular signal transduction (GO:1902533)", 0.28268973579756657, 3.2432026688907425, 4.097479514461909, ["CDH13"], 0.29501187334192785, 0, 0], [143, "negative regulation of cellular macromolecule biosynthetic process (GO:2000113)", 0.28313220058990396, 3.237096237096237, 4.0847018875843455, ["IFNL1"], 0.29501187334192785, 0, 0], [144, "regulation of apoptotic process (GO:0042981)", 0.36478700556273874, 2.3613053613053614, 2.3812386561312207, ["OLFM4"], 0.3774532210336672, 0, 0], [145, "positive regulation of transcription by RNA polymerase II (GO:0045944)", 0.4274816321367295, 1.9124987471183723, 1.6253255035640346, ["CDH13"], 0.43927422888532897, 0, 0], [146, "negative regulation of transcription, DNA-templated (GO:0045892)", 0.4417148744162054, 1.8278775079197465, 1.493541686074466, ["IFNL1"], 0.45079120745215484, 0, 0], [147, "cellular protein modification process (GO:0006464)", 0.46820465573063685, 1.68359375, 1.2775947469347737, ["CHRDL1"], 0.4745747871011217, 0, 0], [148, "regulation of transcription by RNA polymerase II (GO:0006357)", 0.754106540246353, 0.7331684188827046, 0.2069159795658213, ["CDH13"], 0.759201854707477, 0, 0], [149, "regulation of transcription, DNA-templated (GO:0006355)", 0.7603363385910282, 0.7192072305759332, 0.19705874845398563, ["IFNL1"], 0.7603363385910282, 0, 0]], [[1, "lung morphogenesis (GO:0060425)", 0.0014992198216206949, 999.5, 6499.5590198897235, ["NKX2-1"], 0.028448319415720673, 0, 0], [2, "positive regulation of transcription by RNA polymerase II (GO:0045944)", 0.001682410756738403, 21.09281767955801, 134.73095382246856, ["EGR4", "IFNB1", "NKX2-1"], 0.028448319415720673, 0, 0], [3, "epithelial tube branching involved in lung morphogenesis (GO:0060441)", 0.00179884089014784, 799.56, 5053.709147518722, ["NKX2-1"], 0.028448319415720673, 0, 0], [4, "regulation of macromolecule biosynthetic process (GO:0010556)", 0.00179884089014784, 799.56, 5053.709147518722, ["IFNB1"], 0.028448319415720673, 0, 0], [5, "negative regulation of lymphocyte differentiation (GO:0045620)", 0.002098387281973246, 666.2666666666667, 4108.590825691207, ["IFNB1"], 0.028448319415720673, 0, 0], [6, "negative regulation of type 2 immune response (GO:0002829)", 0.002098387281973246, 666.2666666666667, 4108.590825691207, ["IFNB1"], 0.028448319415720673, 0, 0], [7, "regulation of MHC class I biosynthetic process (GO:0045343)", 0.002098387281973246, 666.2666666666667, 4108.590825691207, ["IFNB1"], 0.028448319415720673, 0, 0], [8, "thyroid gland development (GO:0030878)", 0.002397858969227747, 571.0571428571428, 3445.2899826083253, ["NKX2-1"], 0.028448319415720673, 0, 0], [9, "negative regulation of T cell cytokine production (GO:0002725)", 0.0026972559359141816, 499.65, 2955.689739283532, ["IFNB1"], 0.028448319415720673, 0, 0], [10, "positive regulation of circadian rhythm (GO:0042753)", 0.002996578172872153, 444.1111111111111, 2580.4117942926405, ["NKX2-1"], 0.028448319415720673, 0, 0], [11, "regulation of T-helper 2 cell cytokine production (GO:2000551)", 0.0032958256764104633, 399.68, 2284.210591570385, ["IFNB1"], 0.028448319415720673, 0, 0], [12, "positive regulation of transcription, DNA-templated (GO:0045893)", 0.003606272382420998, 15.94406779661017, 89.6866667852248, ["EGR4", "IFNB1", "NKX2-1"], 0.028448319415720673, 0, 0], [13, "negative regulation of T cell differentiation (GO:0045581)", 0.004193119798694676, 307.4, 1682.8029678019434, ["IFNB1"], 0.028448319415720673, 0, 0], [14, "positive regulation of T cell chemotaxis (GO:0010820)", 0.004193119798694676, 307.4, 1682.8029678019434, ["S100A7"], 0.028448319415720673, 0, 0], [15, "cellular response to exogenous dsRNA (GO:0071360)", 0.004492068393214533, 285.42857142857144, 1542.8675927558304, ["IFNB1"], 0.028448319415720673, 0, 0], [16, "regulation of T cell chemotaxis (GO:0010819)", 0.004492068393214533, 285.42857142857144, 1542.8675927558304, ["S100A7"], 0.028448319415720673, 0, 0], [17, "B cell activation involved in immune response (GO:0002312)", 0.004790942275014269, 266.38666666666666, 1422.7786907214238, ["IFNB1"], 0.028448319415720673, 0, 0], [18, "positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141)", 0.0053884659389882355, 235.0235294117647, 1227.644124299904, ["IFNB1"], 0.028448319415720673, 0, 0], [19, "positive regulation of lymphocyte chemotaxis (GO:0140131)", 0.0053884659389882355, 235.0235294117647, 1227.644124299904, ["S100A7"], 0.028448319415720673, 0, 0], [20, "cellular response to dsRNA (GO:0071359)", 0.0053884659389882355, 235.0235294117647, 1227.644124299904, ["IFNB1"], 0.028448319415720673, 0, 0], [21, "regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139)", 0.005687115738983334, 221.95555555555555, 1147.4107993095174, ["IFNB1"], 0.028448319415720673, 0, 0], [22, "positive regulation of monocyte chemotaxis (GO:0090026)", 0.005687115738983334, 221.95555555555555, 1147.4107993095174, ["S100A7"], 0.028448319415720673, 0, 0], [23, "cellular response to interferon-beta (GO:0035458)", 0.0059856908667451705, 210.26315789473685, 1076.2074808846232, ["IFNB1"], 0.028448319415720673, 0, 0], [24, "regulation of granulocyte chemotaxis (GO:0071622)", 0.0059856908667451705, 210.26315789473685, 1076.2074808846232, ["S100A7"], 0.028448319415720673, 0, 0], [25, "natural killer cell activation involved in immune response (GO:0002323)", 0.006284191332539439, 199.74, 1012.6254955871668, ["IFNB1"], 0.028448319415720673, 0, 0], [26, "positive regulation of granulocyte chemotaxis (GO:0071624)", 0.006582617147928667, 190.21904761904761, 955.5316921910462, ["S100A7"], 0.028448319415720673, 0, 0], [27, "lymphocyte activation involved in immune response (GO:0002285)", 0.007179244874171303, 173.66086956521738, 857.2874884567655, ["IFNB1"], 0.028448319415720673, 0, 0], [28, "endocrine system development (GO:0035270)", 0.007179244874171303, 173.66086956521738, 857.2874884567655, ["NKX2-1"], 0.028448319415720673, 0, 0], [29, "response to dsRNA (GO:0043331)", 0.007477446810139074, 166.41666666666666, 814.7533474976135, ["IFNB1"], 0.028448319415720673, 0, 0], [30, "positive regulation of T cell migration (GO:2000406)", 0.007477446810139074, 166.41666666666666, 814.7533474976135, ["S100A7"], 0.028448319415720673, 0, 0], [31, "regulation of monocyte chemotaxis (GO:0090025)", 0.007775574144635047, 159.752, 775.8783981291459, ["S100A7"], 0.028448319415720673, 0, 0], [32, "response to interferon-beta (GO:0035456)", 0.008371605061186147, 147.9037037037037, 707.410051609059, ["IFNB1"], 0.028448319415720673, 0, 0], [33, "T cell activation involved in immune response (GO:0002286)", 0.008371605061186147, 147.9037037037037, 707.410051609059, ["IFNB1"], 0.028448319415720673, 0, 0], [34, "negative regulation of epithelial to mesenchymal transition (GO:0010719)", 0.008669508668721345, 142.61428571428573, 677.1245223853919, ["NKX2-1"], 0.028448319415720673, 0, 0], [35, "protein N-linked glycosylation via asparagine (GO:0018279)", 0.008967337727522093, 137.68965517241378, 649.0919521468393, ["ASGR2"], 0.028448319415720673, 0, 0], [36, "respiratory tube development (GO:0030323)", 0.008967337727522093, 137.68965517241378, 649.0919521468393, ["NKX2-1"], 0.028448319415720673, 0, 0], [37, "peptidyl-asparagine modification (GO:0018196)", 0.009265092249714469, 133.09333333333333, 623.0766346487915, ["ASGR2"], 0.028448319415720673, 0, 0], [38, "positive regulation of mononuclear cell migration (GO:0071677)", 0.009265092249714469, 133.09333333333333, 623.0766346487915, ["S100A7"], 0.028448319415720673, 0, 0], [39, "B cell proliferation (GO:0042100)", 0.00956277225126547, 128.79354838709676, 598.8742368950442, ["IFNB1"], 0.028448319415720673, 0, 0], [40, "respiratory system development (GO:0060541)", 0.010455365255350332, 117.41176470588235, 535.4727918518732, ["NKX2-1"], 0.028448319415720673, 0, 0], [41, "response to exogenous dsRNA (GO:0043330)", 0.010455365255350332, 117.41176470588235, 535.4727918518732, ["IFNB1"], 0.028448319415720673, 0, 0], [42, "cellular response to virus (GO:0098586)", 0.010455365255350332, 117.41176470588235, 535.4727918518732, ["IFNB1"], 0.028448319415720673, 0, 0], [43, "lung development (GO:0030324)", 0.010455365255350332, 117.41176470588235, 535.4727918518732, ["NKX2-1"], 0.028448319415720673, 0, 0], [44, "positive regulation of innate immune response (GO:0045089)", 0.010752747305294047, 114.05142857142857, 516.9488201244333, ["IFNB1"], 0.02859253260725917, 0, 0], [45, "lymphocyte proliferation (GO:0046651)", 0.011347288056139465, 107.87567567567568, 483.15104128778233, ["IFNB1"], 0.028861580490615598, 0, 0], [46, "regulation of apoptotic signaling pathway (GO:2001233)", 0.011347288056139465, 107.87567567567568, 483.15104128778233, ["IFNB1"], 0.028861580490615598, 0, 0], [47, "regulation of T cell differentiation (GO:0045580)", 0.011644446786079536, 105.03157894736842, 467.6978364624713, ["IFNB1"], 0.02898723987172991, 0, 0], [48, "keratinocyte differentiation (GO:0030216)", 0.012238541027235605, 99.77, 439.3037926149688, ["S100A7"], 0.029831443753886785, 0, 0], [49, "natural killer cell activation (GO:0030101)", 0.012832337737452553, 95.00952380952381, 413.84123997008294, ["IFNB1"], 0.03020813330976402, 0, 0], [50, "branching morphogenesis of an epithelial tube (GO:0048754)", 0.013129124551655722, 92.7953488372093, 402.07503337293304, ["NKX2-1"], 0.03020813330976402, 0, 0], [51, "negative regulation of T cell activation (GO:0050868)", 0.013425837026561787, 90.68181818181819, 390.89071422300736, ["IFNB1"], 0.03020813330976402, 0, 0], [52, "positive regulation of response to biotic stimulus (GO:0002833)", 0.013425837026561787, 90.68181818181819, 390.89071422300736, ["IFNB1"], 0.03020813330976402, 0, 0], [53, "epidermal cell differentiation (GO:0009913)", 0.015796862298306416, 76.7, 318.1473007644563, ["S100A7"], 0.03423400079254664, 0, 0], [54, "negative regulation of viral genome replication (GO:0045071)", 0.016092906355470643, 75.24905660377358, 310.73170127161313, ["IFNB1"], 0.03423400079254664, 0, 0], [55, "positive regulation of leukocyte chemotaxis (GO:0002690)", 0.016092906355470643, 75.24905660377358, 310.73170127161313, ["S100A7"], 0.03423400079254664, 0, 0], [56, "positive regulation of apoptotic signaling pathway (GO:2001235)", 0.017572013994556906, 68.7448275862069, 277.8286292162732, ["IFNB1"], 0.0360688708309326, 0, 0], [57, "response to reactive oxygen species (GO:0000302)", 0.017572013994556906, 68.7448275862069, 277.8286292162732, ["S100A7"], 0.0360688708309326, 0, 0], [58, "B cell differentiation (GO:0030183)", 0.01816313808123624, 66.44666666666667, 266.34223514766154, ["IFNB1"], 0.03627612202076156, 0, 0], [59, "regulation of innate immune response (GO:0045088)", 0.0190492685407353, 63.27301587301587, 250.60711544601855, ["IFNB1"], 0.03627612202076156, 0, 0], [60, "antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)", 0.0190492685407353, 63.27301587301587, 250.60711544601855, ["S100A7"], 0.03627612202076156, 0, 0], [61, "type I interferon signaling pathway (GO:0060337)", 0.019344497240045323, 62.28125, 245.72116030177747, ["IFNB1"], 0.03627612202076156, 0, 0], [62, "cellular response to type I interferon (GO:0071357)", 0.019344497240045323, 62.28125, 245.72116030177747, ["IFNB1"], 0.03627612202076156, 0, 0], [63, "protein N-linked glycosylation (GO:0006487)", 0.019934732540743783, 60.38787878787879, 236.43616149285907, ["ASGR2"], 0.03627612202076156, 0, 0], [64, "regulation of viral genome replication (GO:0045069)", 0.019934732540743783, 60.38787878787879, 236.43616149285907, ["IFNB1"], 0.03627612202076156, 0, 0], [65, "negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)", 0.02022973917450602, 59.483582089552236, 232.02175076653654, ["NKX2-1"], 0.03627612202076156, 0, 0], [66, "regulation of transcription by RNA polymerase II (GO:0006357)", 0.020728704660723057, 8.075805719473445, 31.303727572383085, ["EGR4", "IFNB1", "NKX2-1"], 0.03627612202076156, 0, 0], [67, "negative regulation of viral process (GO:0048525)", 0.020819530478468958, 57.7536231884058, 223.6141610659621, ["IFNB1"], 0.03627612202076156, 0, 0], [68, "gland development (GO:0048732)", 0.021114315180935466, 56.925714285714285, 219.60824963740106, ["NKX2-1"], 0.03627612202076156, 0, 0], [69, "defense response to Gram-negative bacterium (GO:0050829)", 0.02170366274746418, 55.33888888888889, 211.9631207182121, ["S100A7"], 0.03627612202076156, 0, 0], [70, "response to molecule of bacterial origin (GO:0002237)", 0.02170366274746418, 55.33888888888889, 211.9631207182121, ["S100A7"], 0.03627612202076156, 0, 0], [71, "positive regulation of immune response (GO:0050778)", 0.022292714638201434, 53.83783783783784, 204.7719659635136, ["IFNB1"], 0.036704085836694246, 0, 0], [72, "regulation of epithelial to mesenchymal transition (GO:0010717)", 0.022587129745657998, 53.117333333333335, 201.3346131407168, ["NKX2-1"], 0.036704085836694246, 0, 0], [73, "skin development (GO:0043588)", 0.023764051554239853, 50.41772151898734, 188.54116752551658, ["S100A7"], 0.03808758947734332, 0, 0], [74, "epidermis development (GO:0008544)", 0.024645967784075077, 48.56585365853658, 179.84625102158773, ["S100A7"], 0.03884637548639252, 0, 0], [75, "lymphocyte differentiation (GO:0030098)", 0.0249397922961005, 47.97831325301205, 177.10189992485337, ["IFNB1"], 0.03884637548639252, 0, 0], [76, "B cell activation (GO:0042113)", 0.02523354305099001, 47.404761904761905, 174.42966577015417, ["IFNB1"], 0.03884637548639252, 0, 0], [77, "T cell activation (GO:0042110)", 0.027287734343433324, 43.74285714285714, 157.5319374528161, ["IFNB1"], 0.04137134334218952, 0, 0], [78, "positive regulation of peptidyl-serine phosphorylation (GO:0033138)", 0.02758089556145968, 43.26521739130435, 155.34947127174277, ["IFNB1"], 0.04137134334218952, 0, 0], [79, "positive regulation of defense response (GO:0031349)", 0.02904559756492306, 41.02474226804124, 145.18198263769264, ["IFNB1"], 0.043016897659443006, 0, 0], [80, "regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)", 0.029630963394411815, 40.19191919191919, 141.432767389918, ["NKX2-1"], 0.04333528396432728, 0, 0], [81, "negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)", 0.0319694869760854, 37.17196261682243, 127.98207714314651, ["NKX2-1"], 0.046178147854345576, 0, 0], [82, "negative regulation of cell motility (GO:2000146)", 0.033720296216731616, 35.18761061946903, 119.27387298714444, ["NKX2-1"], 0.04753342960671806, 0, 0], [83, "response to lipid (GO:0033993)", 0.033720296216731616, 35.18761061946903, 119.27387298714444, ["S100A7"], 0.04753342960671806, 0, 0], [84, "defense response to symbiont (GO:0140546)", 0.036632447786472476, 32.31056910569106, 106.84526455648567, ["IFNB1"], 0.05102376655972952, 0, 0], [85, "defense response to virus (GO:0051607)", 0.03924712768834303, 30.093939393939394, 97.44047472504964, ["IFNB1"], 0.054022516935719224, 0, 0], [86, "positive regulation of response to external stimulus (GO:0032103)", 0.040986960225553155, 28.776811594202897, 91.92756222432686, ["IFNB1"], 0.05576132960918278, 0, 0], [87, "negative regulation of cell migration (GO:0030336)", 0.042434814389666786, 27.763636363636362, 87.72715392092086, ["NKX2-1"], 0.05706750900679326, 0, 0], [88, "brain development (GO:0007420)", 0.04416983459325144, 26.63758389261745, 83.1016220368009, ["NKX2-1"], 0.05872580281148203, 0, 0], [89, "response to lipopolysaccharide (GO:0032496)", 0.046767452580978475, 25.10886075949367, 76.89758784588065, ["S100A7"], 0.061480808449151485, 0, 0], [90, "positive regulation of ERK1 and ERK2 cascade (GO:0070374)", 0.050509180130790456, 23.184795321637427, 69.2205289569504, ["S100A7"], 0.0656619341700276, 0, 0], [91, "defense response to bacterium (GO:0042742)", 0.05165801551321664, 22.650285714285715, 67.11528598348353, ["S100A7"], 0.06641744851699283, 0, 0], [92, "negative regulation of cell differentiation (GO:0045596)", 0.05595583741739159, 20.846315789473685, 60.10394168947767, ["NKX2-1"], 0.07116122801994365, 0, 0], [93, "negative regulation of multicellular organismal process (GO:0051241)", 0.06251430040361035, 18.573708920187794, 51.49300658384643, ["NKX2-1"], 0.07864702308841302, 0, 0], [94, "regulation of ERK1 and ERK2 cascade (GO:0070372)", 0.06931738938855214, 16.672573839662448, 44.500091181655506, ["S100A7"], 0.08627802721766598, 0, 0], [95, "positive regulation of signal transduction (GO:0009967)", 0.07326682369290423, 15.731474103585658, 41.11652611319615, ["IFNB1"], 0.09023387760073469, 0, 0], [96, "central nervous system development (GO:0007417)", 0.07776335159216254, 14.776779026217229, 37.74114992527251, ["NKX2-1"], 0.09477408475294809, 0, 0], [97, "positive regulation of MAPK cascade (GO:0043410)", 0.07944485535766266, 14.447619047619048, 36.59137122245166, ["S100A7"], 0.09582523790563434, 0, 0], [98, "innate immune response (GO:0045087)", 0.0872581320254043, 13.085049833887043, 31.9129254638413, ["S100A7"], 0.10417552496910515, 0, 0], [99, "positive regulation of apoptotic process (GO:0043065)", 0.08948031840285002, 12.741100323624595, 30.753659971516722, ["IFNB1"], 0.10574946720336821, 0, 0], [100, "positive regulation of macromolecule metabolic process (GO:0010604)", 0.10982267971767223, 10.240731070496084, 22.620630189252047, ["NKX2-1"], 0.1284925352696765, 0, 0], [101, "regulation of cell migration (GO:0030334)", 0.11633828630365514, 9.625061425061425, 20.70594294612794, ["NKX2-1"], 0.13476811383690743, 0, 0], [102, "negative regulation of nucleic acid-templated transcription (GO:1903507)", 0.13138696365173613, 8.436717062634989, 17.12323172617443, ["NKX2-1"], 0.1492289500399958, 0, 0], [103, "positive regulation of cell population proliferation (GO:0008284)", 0.13405161943292423, 8.254122621564482, 16.586909784962376, ["EGR4"], 0.1492289500399958, 0, 0], [104, "neutrophil degranulation (GO:0043312)", 0.13591282245621636, 8.130833333333333, 16.22704240839014, ["S100A7"], 0.1492289500399958, 0, 0], [105, "positive regulation of gene expression (GO:0010628)", 0.13617843625530518, 8.113513513513514, 16.176635795129393, ["NKX2-1"], 0.1492289500399958, 0, 0], [106, "cellular response to cytokine stimulus (GO:0071345)", 0.13617843625530518, 8.113513513513514, 16.176635795129393, ["IFNB1"], 0.1492289500399958, 0, 0], [107, "neutrophil activation involved in immune response (GO:0002283)", 0.13697486946968407, 8.061983471074381, 16.026882961137105, ["S100A7"], 0.1492289500399958, 0, 0], [108, "neutrophil mediated immunity (GO:0002446)", 0.13777069069054648, 8.011088295687886, 15.879295928232638, ["S100A7"], 0.1492289500399958, 0, 0], [109, "regulation of transcription, DNA-templated (GO:0006355)", 0.13902526114837216, 3.958965209634255, 7.811432780346923, ["EGR4", "NKX2-1"], 0.1492289500399958, 0, 0], [110, "positive regulation of nucleic acid-templated transcription (GO:1903508)", 0.14385169452323945, 7.64078431372549, 14.815269969426804, ["NKX2-1"], 0.15300589326562744, 0, 0], [111, "negative regulation of cellular macromolecule biosynthetic process (GO:2000113)", 0.15329801811567262, 7.123809523809523, 13.359788791957792, ["NKX2-1"], 0.16158439747327652, 0, 0], [112, "cytokine-mediated signaling pathway (GO:0019221)", 0.17244290587638317, 6.249677419354839, 10.984989739295798, ["IFNB1"], 0.1796078382353798, 0, 0], [113, "positive regulation of cellular process (GO:0048522)", 0.1734673993213497, 6.208333333333333, 10.875544750623106, ["EGR4"], 0.1796078382353798, 0, 0], [114, "negative regulation of transcription by RNA polymerase II (GO:0000122)", 0.18845634920732277, 5.654758418740849, 9.437163376844246, ["NKX2-1"], 0.1934157268180418, 0, 0], [115, "regulation of cell population proliferation (GO:0042127)", 0.20841797228460673, 5.04089121887287, 7.905174674708202, ["EGR4"], 0.21204263267216508, 0, 0], [116, "negative regulation of transcription, DNA-templated (GO:0045892)", 0.25278167769899834, 4.02259767687434, 5.531993369927694, ["NKX2-1"], 0.2549608300929552, 0, 0], [117, "regulation of gene expression (GO:0010468)", 0.2830873472213558, 3.5094619666048237, 4.4289402351621945, ["NKX2-1"], 0.2830873472213558, 0, 0]], [[1, "regulation of growth rate (GO:0040009)", 0.00224816055240216, 624.59375, 3808.549663430724, ["TMPRSS4"], 0.047164363128863705, 0, 0], [2, "sialic acid transport (GO:0015739)", 0.00224816055240216, 624.59375, 3808.549663430724, ["SLC17A4"], 0.047164363128863705, 0, 0], [3, "positive regulation of viral entry into host cell (GO:0046598)", 0.004491844107510829, 277.52777777777777, 1500.1741678966396, ["TMPRSS4"], 0.047164363128863705, 0, 0], [4, "positive regulation by symbiont of entry into host (GO:0075294)", 0.004491844107510829, 277.52777777777777, 1500.1741678966396, ["TMPRSS4"], 0.047164363128863705, 0, 0], [5, "positive regulation of viral life cycle (GO:1903902)", 0.010750337464808102, 108.52173913043478, 491.90930693624915, ["TMPRSS4"], 0.06375157330727682, 0, 0], [6, "positive regulation of leukocyte cell-cell adhesion (GO:1903039)", 0.013866454289070039, 83.17083333333333, 355.82833874131705, ["SIRPG"], 0.06375157330727682, 0, 0], [7, "positive regulation of lymphocyte activation (GO:0051251)", 0.015643173290839224, 73.37132352941177, 305.0574683216414, ["SIRPG"], 0.06375157330727682, 0, 0], [8, "regulation of viral entry into host cell (GO:0046596)", 0.017417046832985512, 65.63486842105263, 265.8412914846341, ["TMPRSS4"], 0.06375157330727682, 0, 0], [9, "regulation of cell-cell adhesion (GO:0022407)", 0.01918807882344009, 59.37202380952381, 234.72528267100722, ["SIRPG"], 0.06375157330727682, 0, 0], [10, "anion transport (GO:0006820)", 0.01918807882344009, 59.37202380952381, 234.72528267100722, ["SLC17A4"], 0.06375157330727682, 0, 0], [11, "positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862)", 0.02095627318649442, 54.19836956521739, 209.49389233222107, ["BMP3"], 0.06375157330727682, 0, 0], [12, "regulation of T cell activation (GO:0050863)", 0.02095627318649442, 54.19836956521739, 209.49389233222107, ["SIRPG"], 0.06375157330727682, 0, 0], [13, "positive regulation of cell-cell adhesion (GO:0022409)", 0.02095627318649442, 54.19836956521739, 209.49389233222107, ["SIRPG"], 0.06375157330727682, 0, 0], [14, "positive regulation of phagocytosis (GO:0050766)", 0.023603252767760232, 47.93028846153846, 179.56463060223416, ["SIRPG"], 0.06375157330727682, 0, 0], [15, "carboxylic acid transport (GO:0046942)", 0.025364370254955197, 44.497767857142854, 163.5030358762894, ["SLC17A4"], 0.06375157330727682, 0, 0], [16, "regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393)", 0.02580420824342157, 43.71491228070175, 159.87495051613905, ["BMP3"], 0.06375157330727682, 0, 0], [17, "regulation of phagocytosis (GO:0050764)", 0.02580420824342157, 43.71491228070175, 159.87495051613905, ["SIRPG"], 0.06375157330727682, 0, 0], [18, "positive regulation of T cell activation (GO:0050870)", 0.03325451045778232, 33.64358108108108, 114.5081106084989, ["SIRPG"], 0.07759385773482542, 0, 0], [19, "positive regulation of cell adhesion (GO:0045785)", 0.03543611612294145, 31.50632911392405, 105.23188749884586, ["SIRPG"], 0.07761242296639746, 0, 0], [20, "sodium ion transport (GO:0006814)", 0.039786204244047274, 27.952247191011235, 90.12461522615385, ["SLC17A4"], 0.07761242296639746, 0, 0], [21, "positive regulation of transport (GO:0051050)", 0.04022025247919156, 27.64027777777778, 88.81884342634399, ["SIRPG"], 0.07761242296639746, 0, 0], [22, "positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100)", 0.040654126315732, 27.335164835164836, 87.54510068843584, ["BMP3"], 0.07761242296639746, 0, 0], [23, "protein maturation (GO:0051604)", 0.04282088157064431, 25.904947916666668, 81.61948121913939, ["TMPRSS4"], 0.07819465330291568, 0, 0], [24, "protein processing (GO:0016485)", 0.046710081786484385, 23.673809523809524, 72.5317052519737, ["TMPRSS4"], 0.08174264312634767, 0, 0], [25, "ion transport (GO:0006811)", 0.051014935889860884, 21.604347826086958, 64.2866930480565, ["SLC17A4"], 0.08570509229496628, 0, 0], [26, "negative regulation of growth (GO:0045926)", 0.05530250201455211, 19.866, 57.51082096679438, ["TMPRSS4"], 0.08933481094658419, 0, 0], [27, "enzyme linked receptor protein signaling pathway (GO:0007167)", 0.06127616634057289, 17.85251798561151, 49.85073415990269, ["ANGPTL1"], 0.09531848097422449, 0, 0], [28, "skeletal system development (GO:0001501)", 0.06890724443039566, 15.79140127388535, 42.24190306488084, ["BMP3"], 0.10336086664559349, 0, 0], [29, "cation transport (GO:0006812)", 0.07564408105928605, 14.31936416184971, 36.968532753958556, ["SLC17A4"], 0.1095534967065522, 0, 0], [30, "regulation of macromolecule metabolic process (GO:0060255)", 0.08649906605727922, 12.4321608040201, 30.429226090981548, ["TMPRSS4"], 0.12109869248019091, 0, 0], [31, "phosphate-containing compound metabolic process (GO:0006796)", 0.0914707296716085, 11.718009478672986, 28.02638807349727, ["SLC17A4"], 0.1239280853615341, 0, 0], [32, "proteolysis (GO:0006508)", 0.12200241335360172, 8.612325174825175, 18.117872942989372, ["TMPRSS4"], 0.16012816752660225, 0, 0], [33, "positive regulation of protein phosphorylation (GO:0001934)", 0.1551122195058613, 6.628716216216216, 12.353318144692642, ["BMP3"], 0.19543203004367343, 0, 0], [34, "negative regulation of cell population proliferation (GO:0008285)", 0.1582068814639261, 6.485780423280423, 11.958817428486013, ["SIRPG"], 0.19543203004367343, 0, 0], [35, "transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)", 0.16781286387234287, 6.075682382133995, 10.844520880520044, ["ANGPTL1"], 0.20137543664681143, 0, 0], [36, "positive regulation of cell population proliferation (GO:0008284)", 0.19419335631720047, 5.158033826638478, 8.453506457263389, ["SIRPG"], 0.22655891570340056, 0, 0], [37, "negative regulation of cellular process (GO:0048523)", 0.22773331955334702, 4.297787610619469, 6.358920531398367, ["SIRPG"], 0.25850809246596146, 0, 0], [38, "positive regulation of cellular process (GO:0048522)", 0.24858393121402697, 3.879607371794872, 5.400315459189092, ["SIRPG"], 0.27475066081550353, 0, 0], [39, "regulation of cell population proliferation (GO:0042127)", 0.29574133486516935, 3.1500655307994756, 3.8376305717304233, ["SIRPG"], 0.3184906683163362, 0, 0], [40, "regulation of gene expression (GO:0010468)", 0.3930084885087277, 2.19306586270872, 2.048156992084284, ["TMPRSS4"], 0.4126589129341641, 0, 0], [41, "regulation of transcription by RNA polymerase II (GO:0006357)", 0.6507822338118429, 1.0082766439909296, 0.4331356854141271, ["ONECUT3"], 0.657438598129094, 0, 0], [42, "regulation of transcription, DNA-templated (GO:0006355)", 0.657438598129094, 0.9890771288452965, 0.414822811338105, ["ONECUT3"], 0.657438598129094, 0, 0]]], "pearson": [[[1, "positive regulation of cell-substrate adhesion (GO:0010811)", 0.0007791063560372328, 58.588235294117645, 419.3372670889321, ["CDH13", "OLFM4"], 0.03649187799249512, 0, 0], [2, "regulation of vesicle-mediated transport (GO:0060627)", 0.0014584201472092786, 42.327659574468086, 276.41661242727787, ["CDH13", "OLFM4"], 0.03649187799249512, 0, 0], [3, "defense response to symbiont (GO:0140546)", 0.0024163697244848196, 32.5672131147541, 196.23338369839547, ["IFNL2", "IFNL1"], 0.03649187799249512, 0, 0], [4, "defense response to virus (GO:0051607)", 0.0027730648199082307, 30.316030534351146, 178.4947893730614, ["IFNL2", "IFNL1"], 0.03649187799249512, 0, 0], [5, "negative regulation of interleukin-13 production (GO:0032696)", 0.002996653029893649, 454.1818181818182, 2638.914119276588, ["IFNL1"], 0.03649187799249512, 0, 0], [6, "negative regulation of interleukin-5 production (GO:0032714)", 0.002996653029893649, 454.1818181818182, 2638.914119276588, ["IFNL1"], 0.03649187799249512, 0, 0], [7, "negative regulation of blood coagulation, intrinsic pathway (GO:2000267)", 0.002996653029893649, 454.1818181818182, 2638.914119276588, ["A2M"], 0.03649187799249512, 0, 0], [8, "positive regulation of MHC class I biosynthetic process (GO:0045345)", 0.002996653029893649, 454.1818181818182, 2638.914119276588, ["IFNL1"], 0.03649187799249512, 0, 0], [9, "regulation of blood coagulation, intrinsic pathway (GO:2000266)", 0.002996653029893649, 454.1818181818182, 2638.914119276588, ["A2M"], 0.03649187799249512, 0, 0], [10, "regulation of neutrophil extravasation (GO:2000389)", 0.0035949984464796287, 363.3272727272727, 2044.8828145385057, ["OLFM4"], 0.03649187799249512, 0, 0], [11, "regulation of type 2 immune response (GO:0002828)", 0.0035949984464796287, 363.3272727272727, 2044.8828145385057, ["IFNL1"], 0.03649187799249512, 0, 0], [12, "keratinocyte proliferation (GO:0043616)", 0.0041930151049605156, 302.75757575757575, 1657.3964565725007, ["CDH13"], 0.03649187799249512, 0, 0], [13, "negative regulation of lymphocyte differentiation (GO:0045620)", 0.0041930151049605156, 302.75757575757575, 1657.3964565725007, ["IFNL1"], 0.03649187799249512, 0, 0], [14, "regulation of necrotic cell death (GO:0010939)", 0.0041930151049605156, 302.75757575757575, 1657.3964565725007, ["OLFM4"], 0.03649187799249512, 0, 0], [15, "negative regulation of type 2 immune response (GO:0002829)", 0.0041930151049605156, 302.75757575757575, 1657.3964565725007, ["IFNL1"], 0.03649187799249512, 0, 0], [16, "regulation of MHC class I biosynthetic process (GO:0045343)", 0.0041930151049605156, 302.75757575757575, 1657.3964565725007, ["IFNL1"], 0.03649187799249512, 0, 0], [17, "sequestering of BMP from receptor via BMP binding (GO:0038098)", 0.00479070309341298, 259.4935064935065, 1385.975083259077, ["CHRDL1"], 0.03649187799249512, 0, 0], [18, "regulation of positive chemotaxis (GO:0050926)", 0.00479070309341298, 259.4935064935065, 1385.975083259077, ["CDH13"], 0.03649187799249512, 0, 0], [19, "positive regulation of endocytic recycling (GO:2001137)", 0.00479070309341298, 259.4935064935065, 1385.975083259077, ["PLA2G4E"], 0.03649187799249512, 0, 0], [20, "regulation of cellular extravasation (GO:0002691)", 0.0053880625223818295, 227.04545454545453, 1185.9876925180256, ["OLFM4"], 0.03649187799249512, 0, 0], [21, "negative regulation of protein activation cascade (GO:2000258)", 0.0053880625223818295, 227.04545454545453, 1185.9876925180256, ["A2M"], 0.03649187799249512, 0, 0], [22, "N-acylphosphatidylethanolamine metabolic process (GO:0070292)", 0.0053880625223818295, 227.04545454545453, 1185.9876925180256, ["PLA2G4E"], 0.03649187799249512, 0, 0], [23, "regulation of neutrophil migration (GO:1902622)", 0.00598509351248777, 201.8080808080808, 1032.9512945731403, ["OLFM4"], 0.037157455556694904, 0, 0], [24, "regulation of memory T cell differentiation (GO:0043380)", 0.00598509351248777, 201.8080808080808, 1032.9512945731403, ["IFNL1"], 0.037157455556694904, 0, 0], [25, "regulation of endocytic recycling (GO:2001135)", 0.006581796197874835, 181.61818181818182, 912.3494182081016, ["PLA2G4E"], 0.039227505339334015, 0, 0], [26, "negative regulation of complement activation (GO:0045916)", 0.007178170714881846, 165.099173553719, 815.046857216495, ["A2M"], 0.040229691526464245, 0, 0], [27, "positive regulation of calcium-mediated signaling (GO:0050850)", 0.007774217207607984, 151.33333333333334, 735.0172993440868, ["CDH13"], 0.040229691526464245, 0, 0], [28, "regulation of interleukin-5 production (GO:0032674)", 0.007774217207607984, 151.33333333333334, 735.0172993440868, ["IFNL1"], 0.040229691526464245, 0, 0], [29, "sequestering of extracellular ligand from receptor (GO:0035581)", 0.008369935820942226, 139.6853146853147, 668.1300945358273, ["CHRDL1"], 0.040229691526464245, 0, 0], [30, "cellular response to low-density lipoprotein particle stimulus (GO:0071404)", 0.008369935820942226, 139.6853146853147, 668.1300945358273, ["CDH13"], 0.040229691526464245, 0, 0], [31, "negative regulation of T cell differentiation (GO:0045581)", 0.008369935820942226, 139.6853146853147, 668.1300945358273, ["IFNL1"], 0.040229691526464245, 0, 0], [32, "negative regulation of immune effector process (GO:0002698)", 0.00956039001281181, 121.04848484848485, 562.8907982194623, ["IFNL1"], 0.04189700329144, 0, 0], [33, "regulation of interleukin-13 production (GO:0032656)", 0.00956039001281181, 121.04848484848485, 562.8907982194623, ["IFNL1"], 0.04189700329144, 0, 0], [34, "regulation of ERBB signaling pathway (GO:1901184)", 0.00956039001281181, 121.04848484848485, 562.8907982194623, ["CDH13"], 0.04189700329144, 0, 0], [35, "positive regulation of positive chemotaxis (GO:0050927)", 0.010155125895608219, 113.47727272727273, 520.8353408254836, ["CDH13"], 0.043231821669874985, 0, 0], [36, "hyaluronan catabolic process (GO:0030214)", 0.010749534506708167, 106.79679144385027, 484.0984098875249, ["HYAL4"], 0.04328866598647343, 0, 0], [37, "phosphatidylinositol acyl-chain remodeling (GO:0036149)", 0.010749534506708167, 106.79679144385027, 484.0984098875249, ["PLA2G4E"], 0.04328866598647343, 0, 0], [38, "Rac protein signal transduction (GO:0016601)", 0.011343616002547938, 100.85858585858585, 451.7557080600296, ["CDH13"], 0.04333843036870879, 0, 0], [39, "glycerolipid catabolic process (GO:0046503)", 0.011343616002547938, 100.85858585858585, 451.7557080600296, ["PLA2G4E"], 0.04333843036870879, 0, 0], [40, "positive regulation of immune system process (GO:0002684)", 0.012530798277531565, 90.76363636363637, 397.50531795625653, ["IFNL1"], 0.04667722358380508, 0, 0], [41, "phosphatidylserine acyl-chain remodeling (GO:0036150)", 0.013123899368825872, 86.43722943722943, 374.56020373045595, ["PLA2G4E"], 0.047529870290991975, 0, 0], [42, "innate immune response (GO:0045087)", 0.013572683267541302, 13.125333333333334, 56.43494440563777, ["IFNL2", "IFNL1"], 0.047529870290991975, 0, 0], [43, "hyaluronan metabolic process (GO:0030212)", 0.013716673976595, 82.50413223140495, 353.872030109198, ["HYAL4"], 0.047529870290991975, 0, 0], [44, "phospholipid catabolic process (GO:0009395)", 0.014309122256811026, 78.91304347826087, 335.1324919763037, ["PLA2G4E"], 0.04845589127874643, 0, 0], [45, "lamellipodium assembly (GO:0030032)", 0.015493040473318351, 72.59272727272727, 302.5203442580517, ["CDH13"], 0.05018397892444423, 0, 0], [46, "phosphatidylethanolamine acyl-chain remodeling (GO:0036152)", 0.015493040473318351, 72.59272727272727, 302.5203442580517, ["PLA2G4E"], 0.05018397892444423, 0, 0], [47, "mucosal immune response (GO:0002385)", 0.01667565529767051, 67.20875420875421, 275.1395602176083, ["IFNL2"], 0.050707604884753184, 0, 0], [48, "glycerophospholipid catabolic process (GO:0046475)", 0.01667565529767051, 67.20875420875421, 275.1395602176083, ["PLA2G4E"], 0.050707604884753184, 0, 0], [49, "regulation of calcium-mediated signaling (GO:0050848)", 0.01667565529767051, 67.20875420875421, 275.1395602176083, ["CDH13"], 0.050707604884753184, 0, 0], [50, "lamellipodium organization (GO:0097581)", 0.017266474337105393, 64.8051948051948, 263.043544162992, ["CDH13"], 0.05145409352457407, 0, 0], [51, "phosphatidylcholine acyl-chain remodeling (GO:0036151)", 0.017856968008938604, 62.56739811912226, 251.8563944353508, ["PLA2G4E"], 0.05186081762570235, 0, 0], [52, "aminoglycan catabolic process (GO:0006026)", 0.018447136470887412, 60.47878787878788, 241.48249384895686, ["HYAL4"], 0.05186081762570235, 0, 0], [53, "phosphatidylethanolamine metabolic process (GO:0046337)", 0.018447136470887412, 60.47878787878788, 241.48249384895686, ["PLA2G4E"], 0.05186081762570235, 0, 0], [54, "positive regulation of receptor signaling pathway via STAT (GO:1904894)", 0.019036979887302796, 58.52492668621701, 231.83899894541258, ["IFNL1"], 0.052527963022372524, 0, 0], [55, "positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427)", 0.01962649841488355, 56.69318181818182, 222.85379213708367, ["IFNL1"], 0.053169968433048165, 0, 0], [56, "phosphatidylserine metabolic process (GO:0006658)", 0.020215692219209058, 54.972451790633606, 214.4638136267328, ["PLA2G4E"], 0.053788181083252666, 0, 0], [57, "negative regulation of cell population proliferation (GO:0008285)", 0.02084945120044108, 10.403713527851458, 40.26682052590156, ["IFNL1", "CDH13"], 0.05402665825304592, 0, 0], [58, "calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339)", 0.021393106288118857, 51.82597402597403, 199.25462501506232, ["CDH13"], 0.05402665825304592, 0, 0], [59, "positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)", 0.021393106288118857, 51.82597402597403, 199.25462501506232, ["OLFM4"], 0.05402665825304592, 0, 0], [60, "negative regulation of innate immune response (GO:0045824)", 0.02256922338610946, 49.01965601965602, 185.84175607013447, ["A2M"], 0.05476766031287691, 0, 0], [61, "positive regulation of intracellular transport (GO:0032388)", 0.02315679597121641, 47.72727272727273, 179.71546945510647, ["PLA2G4E"], 0.05476766031287691, 0, 0], [62, "regulation of T cell differentiation (GO:0045580)", 0.02315679597121641, 47.72727272727273, 179.71546945510647, ["IFNL1"], 0.05476766031287691, 0, 0], [63, "endothelial cell migration (GO:0043542)", 0.02315679597121641, 47.72727272727273, 179.71546945510647, ["CDH13"], 0.05476766031287691, 0, 0], [64, "negative regulation of blood coagulation (GO:0030195)", 0.02374404479036207, 46.5011655011655, 173.93405340895535, ["A2M"], 0.05492900806916125, 0, 0], [65, "epithelial cell migration (GO:0010631)", 0.024330970017212364, 45.336363636363636, 168.47016546086343, ["CDH13"], 0.05492900806916125, 0, 0], [66, "visual system development (GO:0150063)", 0.024330970017212364, 45.336363636363636, 168.47016546086343, ["CHRDL1"], 0.05492900806916125, 0, 0], [67, "positive regulation of cell-matrix adhesion (GO:0001954)", 0.026089805695170006, 42.167019027484145, 153.74983290143678, ["CDH13"], 0.05641460301136417, 0, 0], [68, "regulation of receptor signaling pathway via JAK-STAT (GO:0046425)", 0.026675438127783887, 41.20661157024794, 149.33325716982057, ["IFNL1"], 0.05641460301136417, 0, 0], [69, "negative regulation of T cell activation (GO:0050868)", 0.026675438127783887, 41.20661157024794, 149.33325716982057, ["IFNL1"], 0.05641460301136417, 0, 0], [70, "positive regulation of chemotaxis (GO:0050921)", 0.026675438127783887, 41.20661157024794, 149.33325716982057, ["CDH13"], 0.05641460301136417, 0, 0], [71, "positive regulation of response to stimulus (GO:0048584)", 0.02726074776388067, 40.28888888888889, 145.1329634798573, ["IFNL1"], 0.05641460301136417, 0, 0], [72, "positive regulation of smooth muscle cell proliferation (GO:0048661)", 0.02726074776388067, 40.28888888888889, 145.1329634798573, ["CDH13"], 0.05641460301136417, 0, 0], [73, "adherens junction organization (GO:0034332)", 0.029014741507151904, 37.765151515151516, 133.68679532449664, ["CDH13"], 0.05842157411575181, 0, 0], [74, "regulation of smooth muscle cell proliferation (GO:0048660)", 0.029014741507151904, 37.765151515151516, 133.68679532449664, ["CDH13"], 0.05842157411575181, 0, 0], [75, "positive regulation of cell morphogenesis involved in differentiation (GO:0010770)", 0.029598761568907096, 36.99257884972171, 130.2147194065139, ["OLFM4"], 0.05877063520256545, 0, 0], [76, "regulation of substrate adhesion-dependent cell spreading (GO:1900024)", 0.030182459639590885, 36.25090909090909, 126.89610172901739, ["OLFM4"], 0.05877063520256545, 0, 0], [77, "negative regulation of BMP signaling pathway (GO:0030514)", 0.030765835877853052, 35.53832442067736, 123.7213609818225, ["CHRDL1"], 0.05877063520256545, 0, 0], [78, "sprouting angiogenesis (GO:0002040)", 0.030765835877853052, 35.53832442067736, 123.7213609818225, ["CDH13"], 0.05877063520256545, 0, 0], [79, "glycosaminoglycan metabolic process (GO:0030203)", 0.03193162350337226, 34.19382504288165, 117.76895070161899, ["HYAL4"], 0.05935630505096695, 0, 0], [80, "cellular response to cytokine stimulus (GO:0071345)", 0.032604577769221134, 8.128333333333334, 27.825744455648255, ["IFNL2", "IFNL1"], 0.05935630505096695, 0, 0], [81, "glycosaminoglycan catabolic process (GO:0006027)", 0.03309612573679984, 32.94710743801653, 112.2949128878184, ["HYAL4"], 0.05935630505096695, 0, 0], [82, "Rho protein signal transduction (GO:0007266)", 0.03309612573679984, 32.94710743801653, 112.2949128878184, ["CDH13"], 0.05935630505096695, 0, 0], [83, "sensory organ development (GO:0007423)", 0.03309612573679984, 32.94710743801653, 112.2949128878184, ["CHRDL1"], 0.05935630505096695, 0, 0], [84, "positive regulation of interferon-gamma production (GO:0032729)", 0.03367789522880521, 32.357142857142854, 109.72027527854156, ["IFNL1"], 0.05935630505096695, 0, 0], [85, "eye development (GO:0001654)", 0.03425934385492052, 31.78787878787879, 107.24581633848625, ["CHRDL1"], 0.05935630505096695, 0, 0], [86, "regulation of phagocytosis (GO:0050764)", 0.03425934385492052, 31.78787878787879, 107.24581633848625, ["OLFM4"], 0.05935630505096695, 0, 0], [87, "positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)", 0.034840471769761905, 31.238244514106583, 104.86602418496526, ["IFNL1"], 0.05966931372062671, 0, 0], [88, "homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)", 0.035421279144613474, 30.70724191063174, 102.57577696947945, ["CDH13"], 0.059974665824402355, 0, 0], [89, "regulation of endocytosis (GO:0030100)", 0.03600176612865679, 30.193939393939395, 100.37030934492944, ["CDH13"], 0.060272619698537776, 0, 0], [90, "antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)", 0.037741306359582505, 28.751803751803752, 94.21966448632159, ["CXCL14"], 0.06232269598711797, 0, 0], [91, "regulation of cell-matrix adhesion (GO:0001952)", 0.038320513395665175, 28.301136363636363, 92.31179552985674, ["CDH13"], 0.06232269598711797, 0, 0], [92, "extracellular matrix disassembly (GO:0022617)", 0.03889940085101994, 27.864335664335666, 90.46926829385504, ["A2M"], 0.06232269598711797, 0, 0], [93, "cellular component disassembly (GO:0022411)", 0.03889940085101994, 27.864335664335666, 90.46926829385504, ["A2M"], 0.06232269598711797, 0, 0], [94, "regulation of epidermal growth factor receptor signaling pathway (GO:0042058)", 0.039477968873990896, 27.44077134986226, 88.6889163609223, ["CDH13"], 0.06257678044919833, 0, 0], [95, "regulation of tyrosine phosphorylation of STAT protein (GO:0042509)", 0.040056217631282115, 27.029850746268657, 86.96777093294467, ["IFNL1"], 0.0628250150216951, 0, 0], [96, "negative regulation of cell adhesion (GO:0007162)", 0.042942678013426154, 25.146464646464647, 79.15828251915687, ["CDH13"], 0.0666506148333385, 0, 0], [97, "negative regulation of cellular process (GO:0048523)", 0.043734808326550065, 6.887943262411348, 21.556582758480396, ["IFNL1", "CDH13"], 0.06674922034548711, 0, 0], [98, "positive regulation of immune response (GO:0050778)", 0.04409503288389166, 24.464373464373466, 76.36329437117712, ["IFNL1"], 0.06674922034548711, 0, 0], [99, "phospholipid metabolic process (GO:0006644)", 0.04467073326473782, 24.136969696969697, 75.02824312324114, ["PLA2G4E"], 0.06674922034548711, 0, 0], [100, "phosphatidylcholine metabolic process (GO:0046470)", 0.04524611580465905, 23.818181818181817, 73.7324794714548, ["PLA2G4E"], 0.06674922034548711, 0, 0], [101, "positive regulation of endothelial cell proliferation (GO:0001938)", 0.04524611580465905, 23.818181818181817, 73.7324794714548, ["CDH13"], 0.06674922034548711, 0, 0], [102, "glycerophospholipid metabolic process (GO:0006650)", 0.04697035804559035, 22.9102416570771, 70.06498436559322, ["PLA2G4E"], 0.06861356224306825, 0, 0], [103, "cell-cell junction organization (GO:0045216)", 0.04811826663840212, 22.342312008978677, 67.78866163441084, ["CDH13"], 0.06960797795263997, 0, 0], [104, "regulation of interferon-gamma production (GO:0032649)", 0.05041028257884421, 21.28663101604278, 63.595089599609956, ["IFNL1"], 0.07222242407930565, 0, 0], [105, "cytokine-mediated signaling pathway (GO:0019221)", 0.051702535837496774, 6.258158319870759, 18.538219780322443, ["IFNL2", "IFNL1"], 0.073368360378924, 0, 0], [106, "regulation of endothelial cell proliferation (GO:0001936)", 0.05383882244884977, 19.877122877122876, 58.07619178413111, ["CDH13"], 0.07567909947998694, 0, 0], [107, "regulation of cell death (GO:0010941)", 0.059527849199832554, 17.900090009000902, 50.50172123995827, ["OLFM4"], 0.08289392084836496, 0, 0], [108, "phosphatidylinositol metabolic process (GO:0046488)", 0.06518550479553244, 16.27927927927928, 44.450867603715174, ["PLA2G4E"], 0.08993185383828085, 0, 0], [109, "cellular amide metabolic process (GO:0043603)", 0.06687670762493306, 15.848484848484848, 42.86863861107806, ["PLA2G4E"], 0.09141861867995436, 0, 0], [110, "positive regulation of epithelial cell proliferation (GO:0050679)", 0.07137287991941299, 14.80327868852459, 39.07824746413377, ["CDH13"], 0.09667781007265941, 0, 0], [111, "platelet degranulation (GO:0002576)", 0.07249381569444491, 14.563049853372434, 38.21714214339772, ["A2M"], 0.09731151836461524, 0, 0], [112, "regulation of cell population proliferation (GO:0042127)", 0.07465128685434329, 5.046194225721785, 13.094508250641674, ["IFNL1", "CDH13"], 0.09854038156732244, 0, 0], [113, "positive regulation of macromolecule biosynthetic process (GO:0010557)", 0.07473196722890896, 14.105113636363637, 36.58651144234639, ["IFNL1"], 0.09854038156732244, 0, 0], [114, "regulation of cell adhesion (GO:0030155)", 0.07696516706764417, 13.674931129476583, 35.06802532248599, ["CDH13"], 0.10044244763977078, 0, 0], [115, "positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)", 0.0775226944870714, 13.571428571428571, 34.70464751040876, ["IFNL1"], 0.10044244763977078, 0, 0], [116, "regulation of cellular component organization (GO:0051128)", 0.08030570414317773, 13.076416337285902, 32.97760560549118, ["CDH13"], 0.10315129239080588, 0, 0], [117, "regulation of small GTPase mediated signal transduction (GO:0051056)", 0.08141675143721483, 12.888311688311688, 32.32613131615323, ["A2M"], 0.10350678154986107, 0, 0], [118, "Ras protein signal transduction (GO:0007265)", 0.08197181357640004, 12.796260477111542, 32.008307827212725, ["CDH13"], 0.10350678154986107, 0, 0], [119, "cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)", 0.09738928736005688, 10.661108122646585, 24.830137244993452, ["CDH13"], 0.1219412085432645, 0, 0], [120, "negative regulation of immune response (GO:0050777)", 0.10175047824033288, 10.175141242937853, 23.252555875085513, ["IFNL1"], 0.12559692854058374, 0, 0], [121, "regulation of immune response (GO:0050776)", 0.10229426679107169, 10.117466802860061, 23.06682926467287, ["IFNL1"], 0.12559692854058374, 0, 0], [122, "regulated exocytosis (GO:0045055)", 0.10283775357014241, 10.060436769933977, 22.883497050073817, ["A2M"], 0.12559692854058374, 0, 0], [123, "negative regulation of cytokine production (GO:0001818)", 0.10392382237785831, 9.948267202410848, 22.52384317538298, ["IFNL1"], 0.12589145962846252, 0, 0], [124, "regulation of programmed cell death (GO:0043067)", 0.1104149663820142, 9.324069712670749, 20.545677022917864, ["OLFM4"], 0.13267604831387192, 0, 0], [125, "phosphate-containing compound metabolic process (GO:0006796)", 0.12007089711947924, 8.520896165445928, 18.061512696944295, ["PLA2G4E"], 0.14312450936641924, 0, 0], [126, "positive regulation of cell motility (GO:2000147)", 0.1248627470990637, 8.168595041322314, 16.99509010087468, ["CDH13"], 0.14765515331555945, 0, 0], [127, "positive regulation of cell migration (GO:0030335)", 0.15001775039031348, 6.689280868385346, 12.689576884452375, ["CDH13"], 0.17600507722958036, 0, 0], [128, "plasma membrane bounded cell projection assembly (GO:0120031)", 0.15465986057932218, 6.468985887758451, 12.074536959698023, ["CDH13"], 0.18003374395561722, 0, 0], [129, "positive regulation of transcription, DNA-templated (GO:0045893)", 0.15589083664952325, 3.1849280270956815, 5.919504943584241, ["IFNL1", "CDH13"], 0.18005995861068966, 0, 0], [130, "extracellular matrix organization (GO:0030198)", 0.16590957450841412, 5.986318029796291, 10.753297133202047, ["A2M"], 0.19015789693656693, 0, 0], [131, "positive regulation of cytokine production (GO:0001819)", 0.18352431992317214, 5.349482852476864, 9.069556487367386, ["IFNL1"], 0.20874140205002023, 0, 0], [132, "post-translational protein modification (GO:0043687)", 0.18849409594421104, 5.191331923890063, 8.662716368209253, ["CHRDL1"], 0.2127698507249049, 0, 0], [133, "regulation of cell migration (GO:0030334)", 0.21917141641280938, 4.373687737324101, 6.638825567444713, ["CDH13"], 0.245537902597809, 0, 0], [134, "cellular protein metabolic process (GO:0044267)", 0.2234660366325064, 4.2770979020979025, 6.409213404377618, ["CHRDL1"], 0.24848089147942873, 0, 0], [135, "regulation of intracellular signal transduction (GO:1902531)", 0.23293222567035762, 4.076730608840701, 5.939828070057347, ["A2M"], 0.2570881601843206, 0, 0], [136, "negative regulation of nucleic acid-templated transcription (GO:1903507)", 0.24554381708103362, 3.833693304535637, 5.383578322629747, ["IFNL1"], 0.26901491724319126, 0, 0], [137, "positive regulation of cell population proliferation (GO:0008284)", 0.2501663356311247, 3.750720738035749, 5.197108325087597, ["CDH13"], 0.2720787153944349, 0, 0], [138, "neutrophil degranulation (GO:0043312)", 0.25338663554284113, 3.69469696969697, 5.072223180750502, ["OLFM4"], 0.273089598109254, 0, 0], [139, "neutrophil activation involved in immune response (GO:0002283)", 0.2552211099302061, 3.663410969196093, 5.002845647927838, ["OLFM4"], 0.273089598109254, 0, 0], [140, "neutrophil mediated immunity (GO:0002446)", 0.2565942532570172, 3.6402837408997573, 4.951729532081089, ["OLFM4"], 0.273089598109254, 0, 0], [141, "positive regulation of nucleic acid-templated transcription (GO:1903508)", 0.26704483779082666, 3.4720142602495545, 4.584234804758777, ["IFNL1"], 0.28219631794917144, 0, 0], [142, "positive regulation of intracellular signal transduction (GO:1902533)", 0.28268973579756657, 3.2432026688907425, 4.097479514461909, ["CDH13"], 0.29501187334192785, 0, 0], [143, "negative regulation of cellular macromolecule biosynthetic process (GO:2000113)", 0.28313220058990396, 3.237096237096237, 4.0847018875843455, ["IFNL1"], 0.29501187334192785, 0, 0], [144, "regulation of apoptotic process (GO:0042981)", 0.36478700556273874, 2.3613053613053614, 2.3812386561312207, ["OLFM4"], 0.3774532210336672, 0, 0], [145, "positive regulation of transcription by RNA polymerase II (GO:0045944)", 0.4274816321367295, 1.9124987471183723, 1.6253255035640346, ["CDH13"], 0.43927422888532897, 0, 0], [146, "negative regulation of transcription, DNA-templated (GO:0045892)", 0.4417148744162054, 1.8278775079197465, 1.493541686074466, ["IFNL1"], 0.45079120745215484, 0, 0], [147, "cellular protein modification process (GO:0006464)", 0.46820465573063685, 1.68359375, 1.2775947469347737, ["CHRDL1"], 0.4745747871011217, 0, 0], [148, "regulation of transcription by RNA polymerase II (GO:0006357)", 0.754106540246353, 0.7331684188827046, 0.2069159795658213, ["CDH13"], 0.759201854707477, 0, 0], [149, "regulation of transcription, DNA-templated (GO:0006355)", 0.7603363385910282, 0.7192072305759332, 0.19705874845398563, ["IFNL1"], 0.7603363385910282, 0, 0]], [[1, "lung morphogenesis (GO:0060425)", 0.0014992198216206949, 999.5, 6499.5590198897235, ["NKX2-1"], 0.028448319415720673, 0, 0], [2, "positive regulation of transcription by RNA polymerase II (GO:0045944)", 0.001682410756738403, 21.09281767955801, 134.73095382246856, ["EGR4", "IFNB1", "NKX2-1"], 0.028448319415720673, 0, 0], [3, "epithelial tube branching involved in lung morphogenesis (GO:0060441)", 0.00179884089014784, 799.56, 5053.709147518722, ["NKX2-1"], 0.028448319415720673, 0, 0], [4, "regulation of macromolecule biosynthetic process (GO:0010556)", 0.00179884089014784, 799.56, 5053.709147518722, ["IFNB1"], 0.028448319415720673, 0, 0], [5, "negative regulation of lymphocyte differentiation (GO:0045620)", 0.002098387281973246, 666.2666666666667, 4108.590825691207, ["IFNB1"], 0.028448319415720673, 0, 0], [6, "negative regulation of type 2 immune response (GO:0002829)", 0.002098387281973246, 666.2666666666667, 4108.590825691207, ["IFNB1"], 0.028448319415720673, 0, 0], [7, "regulation of MHC class I biosynthetic process (GO:0045343)", 0.002098387281973246, 666.2666666666667, 4108.590825691207, ["IFNB1"], 0.028448319415720673, 0, 0], [8, "thyroid gland development (GO:0030878)", 0.002397858969227747, 571.0571428571428, 3445.2899826083253, ["NKX2-1"], 0.028448319415720673, 0, 0], [9, "negative regulation of T cell cytokine production (GO:0002725)", 0.0026972559359141816, 499.65, 2955.689739283532, ["IFNB1"], 0.028448319415720673, 0, 0], [10, "positive regulation of circadian rhythm (GO:0042753)", 0.002996578172872153, 444.1111111111111, 2580.4117942926405, ["NKX2-1"], 0.028448319415720673, 0, 0], [11, "regulation of T-helper 2 cell cytokine production (GO:2000551)", 0.0032958256764104633, 399.68, 2284.210591570385, ["IFNB1"], 0.028448319415720673, 0, 0], [12, "positive regulation of transcription, DNA-templated (GO:0045893)", 0.003606272382420998, 15.94406779661017, 89.6866667852248, ["EGR4", "IFNB1", "NKX2-1"], 0.028448319415720673, 0, 0], [13, "negative regulation of T cell differentiation (GO:0045581)", 0.004193119798694676, 307.4, 1682.8029678019434, ["IFNB1"], 0.028448319415720673, 0, 0], [14, "positive regulation of T cell chemotaxis (GO:0010820)", 0.004193119798694676, 307.4, 1682.8029678019434, ["S100A7"], 0.028448319415720673, 0, 0], [15, "cellular response to exogenous dsRNA (GO:0071360)", 0.004492068393214533, 285.42857142857144, 1542.8675927558304, ["IFNB1"], 0.028448319415720673, 0, 0], [16, "regulation of T cell chemotaxis (GO:0010819)", 0.004492068393214533, 285.42857142857144, 1542.8675927558304, ["S100A7"], 0.028448319415720673, 0, 0], [17, "B cell activation involved in immune response (GO:0002312)", 0.004790942275014269, 266.38666666666666, 1422.7786907214238, ["IFNB1"], 0.028448319415720673, 0, 0], [18, "positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141)", 0.0053884659389882355, 235.0235294117647, 1227.644124299904, ["IFNB1"], 0.028448319415720673, 0, 0], [19, "positive regulation of lymphocyte chemotaxis (GO:0140131)", 0.0053884659389882355, 235.0235294117647, 1227.644124299904, ["S100A7"], 0.028448319415720673, 0, 0], [20, "cellular response to dsRNA (GO:0071359)", 0.0053884659389882355, 235.0235294117647, 1227.644124299904, ["IFNB1"], 0.028448319415720673, 0, 0], [21, "regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139)", 0.005687115738983334, 221.95555555555555, 1147.4107993095174, ["IFNB1"], 0.028448319415720673, 0, 0], [22, "positive regulation of monocyte chemotaxis (GO:0090026)", 0.005687115738983334, 221.95555555555555, 1147.4107993095174, ["S100A7"], 0.028448319415720673, 0, 0], [23, "cellular response to interferon-beta (GO:0035458)", 0.0059856908667451705, 210.26315789473685, 1076.2074808846232, ["IFNB1"], 0.028448319415720673, 0, 0], [24, "regulation of granulocyte chemotaxis (GO:0071622)", 0.0059856908667451705, 210.26315789473685, 1076.2074808846232, ["S100A7"], 0.028448319415720673, 0, 0], [25, "natural killer cell activation involved in immune response (GO:0002323)", 0.006284191332539439, 199.74, 1012.6254955871668, ["IFNB1"], 0.028448319415720673, 0, 0], [26, "positive regulation of granulocyte chemotaxis (GO:0071624)", 0.006582617147928667, 190.21904761904761, 955.5316921910462, ["S100A7"], 0.028448319415720673, 0, 0], [27, "lymphocyte activation involved in immune response (GO:0002285)", 0.007179244874171303, 173.66086956521738, 857.2874884567655, ["IFNB1"], 0.028448319415720673, 0, 0], [28, "endocrine system development (GO:0035270)", 0.007179244874171303, 173.66086956521738, 857.2874884567655, ["NKX2-1"], 0.028448319415720673, 0, 0], [29, "response to dsRNA (GO:0043331)", 0.007477446810139074, 166.41666666666666, 814.7533474976135, ["IFNB1"], 0.028448319415720673, 0, 0], [30, "positive regulation of T cell migration (GO:2000406)", 0.007477446810139074, 166.41666666666666, 814.7533474976135, ["S100A7"], 0.028448319415720673, 0, 0], [31, "regulation of monocyte chemotaxis (GO:0090025)", 0.007775574144635047, 159.752, 775.8783981291459, ["S100A7"], 0.028448319415720673, 0, 0], [32, "response to interferon-beta (GO:0035456)", 0.008371605061186147, 147.9037037037037, 707.410051609059, ["IFNB1"], 0.028448319415720673, 0, 0], [33, "T cell activation involved in immune response (GO:0002286)", 0.008371605061186147, 147.9037037037037, 707.410051609059, ["IFNB1"], 0.028448319415720673, 0, 0], [34, "negative regulation of epithelial to mesenchymal transition (GO:0010719)", 0.008669508668721345, 142.61428571428573, 677.1245223853919, ["NKX2-1"], 0.028448319415720673, 0, 0], [35, "protein N-linked glycosylation via asparagine (GO:0018279)", 0.008967337727522093, 137.68965517241378, 649.0919521468393, ["ASGR2"], 0.028448319415720673, 0, 0], [36, "respiratory tube development (GO:0030323)", 0.008967337727522093, 137.68965517241378, 649.0919521468393, ["NKX2-1"], 0.028448319415720673, 0, 0], [37, "peptidyl-asparagine modification (GO:0018196)", 0.009265092249714469, 133.09333333333333, 623.0766346487915, ["ASGR2"], 0.028448319415720673, 0, 0], [38, "positive regulation of mononuclear cell migration (GO:0071677)", 0.009265092249714469, 133.09333333333333, 623.0766346487915, ["S100A7"], 0.028448319415720673, 0, 0], [39, "B cell proliferation (GO:0042100)", 0.00956277225126547, 128.79354838709676, 598.8742368950442, ["IFNB1"], 0.028448319415720673, 0, 0], [40, "respiratory system development (GO:0060541)", 0.010455365255350332, 117.41176470588235, 535.4727918518732, ["NKX2-1"], 0.028448319415720673, 0, 0], [41, "response to exogenous dsRNA (GO:0043330)", 0.010455365255350332, 117.41176470588235, 535.4727918518732, ["IFNB1"], 0.028448319415720673, 0, 0], [42, "cellular response to virus (GO:0098586)", 0.010455365255350332, 117.41176470588235, 535.4727918518732, ["IFNB1"], 0.028448319415720673, 0, 0], [43, "lung development (GO:0030324)", 0.010455365255350332, 117.41176470588235, 535.4727918518732, ["NKX2-1"], 0.028448319415720673, 0, 0], [44, "positive regulation of innate immune response (GO:0045089)", 0.010752747305294047, 114.05142857142857, 516.9488201244333, ["IFNB1"], 0.02859253260725917, 0, 0], [45, "lymphocyte proliferation (GO:0046651)", 0.011347288056139465, 107.87567567567568, 483.15104128778233, ["IFNB1"], 0.028861580490615598, 0, 0], [46, "regulation of apoptotic signaling pathway (GO:2001233)", 0.011347288056139465, 107.87567567567568, 483.15104128778233, ["IFNB1"], 0.028861580490615598, 0, 0], [47, "regulation of T cell differentiation (GO:0045580)", 0.011644446786079536, 105.03157894736842, 467.6978364624713, ["IFNB1"], 0.02898723987172991, 0, 0], [48, "keratinocyte differentiation (GO:0030216)", 0.012238541027235605, 99.77, 439.3037926149688, ["S100A7"], 0.029831443753886785, 0, 0], [49, "natural killer cell activation (GO:0030101)", 0.012832337737452553, 95.00952380952381, 413.84123997008294, ["IFNB1"], 0.03020813330976402, 0, 0], [50, "branching morphogenesis of an epithelial tube (GO:0048754)", 0.013129124551655722, 92.7953488372093, 402.07503337293304, ["NKX2-1"], 0.03020813330976402, 0, 0], [51, "negative regulation of T cell activation (GO:0050868)", 0.013425837026561787, 90.68181818181819, 390.89071422300736, ["IFNB1"], 0.03020813330976402, 0, 0], [52, "positive regulation of response to biotic stimulus (GO:0002833)", 0.013425837026561787, 90.68181818181819, 390.89071422300736, ["IFNB1"], 0.03020813330976402, 0, 0], [53, "epidermal cell differentiation (GO:0009913)", 0.015796862298306416, 76.7, 318.1473007644563, ["S100A7"], 0.03423400079254664, 0, 0], [54, "negative regulation of viral genome replication (GO:0045071)", 0.016092906355470643, 75.24905660377358, 310.73170127161313, ["IFNB1"], 0.03423400079254664, 0, 0], [55, "positive regulation of leukocyte chemotaxis (GO:0002690)", 0.016092906355470643, 75.24905660377358, 310.73170127161313, ["S100A7"], 0.03423400079254664, 0, 0], [56, "positive regulation of apoptotic signaling pathway (GO:2001235)", 0.017572013994556906, 68.7448275862069, 277.8286292162732, ["IFNB1"], 0.0360688708309326, 0, 0], [57, "response to reactive oxygen species (GO:0000302)", 0.017572013994556906, 68.7448275862069, 277.8286292162732, ["S100A7"], 0.0360688708309326, 0, 0], [58, "B cell differentiation (GO:0030183)", 0.01816313808123624, 66.44666666666667, 266.34223514766154, ["IFNB1"], 0.03627612202076156, 0, 0], [59, "regulation of innate immune response (GO:0045088)", 0.0190492685407353, 63.27301587301587, 250.60711544601855, ["IFNB1"], 0.03627612202076156, 0, 0], [60, "antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)", 0.0190492685407353, 63.27301587301587, 250.60711544601855, ["S100A7"], 0.03627612202076156, 0, 0], [61, "type I interferon signaling pathway (GO:0060337)", 0.019344497240045323, 62.28125, 245.72116030177747, ["IFNB1"], 0.03627612202076156, 0, 0], [62, "cellular response to type I interferon (GO:0071357)", 0.019344497240045323, 62.28125, 245.72116030177747, ["IFNB1"], 0.03627612202076156, 0, 0], [63, "protein N-linked glycosylation (GO:0006487)", 0.019934732540743783, 60.38787878787879, 236.43616149285907, ["ASGR2"], 0.03627612202076156, 0, 0], [64, "regulation of viral genome replication (GO:0045069)", 0.019934732540743783, 60.38787878787879, 236.43616149285907, ["IFNB1"], 0.03627612202076156, 0, 0], [65, "negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)", 0.02022973917450602, 59.483582089552236, 232.02175076653654, ["NKX2-1"], 0.03627612202076156, 0, 0], [66, "regulation of transcription by RNA polymerase II (GO:0006357)", 0.020728704660723057, 8.075805719473445, 31.303727572383085, ["EGR4", "IFNB1", "NKX2-1"], 0.03627612202076156, 0, 0], [67, "negative regulation of viral process (GO:0048525)", 0.020819530478468958, 57.7536231884058, 223.6141610659621, ["IFNB1"], 0.03627612202076156, 0, 0], [68, "gland development (GO:0048732)", 0.021114315180935466, 56.925714285714285, 219.60824963740106, ["NKX2-1"], 0.03627612202076156, 0, 0], [69, "defense response to Gram-negative bacterium (GO:0050829)", 0.02170366274746418, 55.33888888888889, 211.9631207182121, ["S100A7"], 0.03627612202076156, 0, 0], [70, "response to molecule of bacterial origin (GO:0002237)", 0.02170366274746418, 55.33888888888889, 211.9631207182121, ["S100A7"], 0.03627612202076156, 0, 0], [71, "positive regulation of immune response (GO:0050778)", 0.022292714638201434, 53.83783783783784, 204.7719659635136, ["IFNB1"], 0.036704085836694246, 0, 0], [72, "regulation of epithelial to mesenchymal transition (GO:0010717)", 0.022587129745657998, 53.117333333333335, 201.3346131407168, ["NKX2-1"], 0.036704085836694246, 0, 0], [73, "skin development (GO:0043588)", 0.023764051554239853, 50.41772151898734, 188.54116752551658, ["S100A7"], 0.03808758947734332, 0, 0], [74, "epidermis development (GO:0008544)", 0.024645967784075077, 48.56585365853658, 179.84625102158773, ["S100A7"], 0.03884637548639252, 0, 0], [75, "lymphocyte differentiation (GO:0030098)", 0.0249397922961005, 47.97831325301205, 177.10189992485337, ["IFNB1"], 0.03884637548639252, 0, 0], [76, "B cell activation (GO:0042113)", 0.02523354305099001, 47.404761904761905, 174.42966577015417, ["IFNB1"], 0.03884637548639252, 0, 0], [77, "T cell activation (GO:0042110)", 0.027287734343433324, 43.74285714285714, 157.5319374528161, ["IFNB1"], 0.04137134334218952, 0, 0], [78, "positive regulation of peptidyl-serine phosphorylation (GO:0033138)", 0.02758089556145968, 43.26521739130435, 155.34947127174277, ["IFNB1"], 0.04137134334218952, 0, 0], [79, "positive regulation of defense response (GO:0031349)", 0.02904559756492306, 41.02474226804124, 145.18198263769264, ["IFNB1"], 0.043016897659443006, 0, 0], [80, "regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)", 0.029630963394411815, 40.19191919191919, 141.432767389918, ["NKX2-1"], 0.04333528396432728, 0, 0], [81, "negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)", 0.0319694869760854, 37.17196261682243, 127.98207714314651, ["NKX2-1"], 0.046178147854345576, 0, 0], [82, "negative regulation of cell motility (GO:2000146)", 0.033720296216731616, 35.18761061946903, 119.27387298714444, ["NKX2-1"], 0.04753342960671806, 0, 0], [83, "response to lipid (GO:0033993)", 0.033720296216731616, 35.18761061946903, 119.27387298714444, ["S100A7"], 0.04753342960671806, 0, 0], [84, "defense response to symbiont (GO:0140546)", 0.036632447786472476, 32.31056910569106, 106.84526455648567, ["IFNB1"], 0.05102376655972952, 0, 0], [85, "defense response to virus (GO:0051607)", 0.03924712768834303, 30.093939393939394, 97.44047472504964, ["IFNB1"], 0.054022516935719224, 0, 0], [86, "positive regulation of response to external stimulus (GO:0032103)", 0.040986960225553155, 28.776811594202897, 91.92756222432686, ["IFNB1"], 0.05576132960918278, 0, 0], [87, "negative regulation of cell migration (GO:0030336)", 0.042434814389666786, 27.763636363636362, 87.72715392092086, ["NKX2-1"], 0.05706750900679326, 0, 0], [88, "brain development (GO:0007420)", 0.04416983459325144, 26.63758389261745, 83.1016220368009, ["NKX2-1"], 0.05872580281148203, 0, 0], [89, "response to lipopolysaccharide (GO:0032496)", 0.046767452580978475, 25.10886075949367, 76.89758784588065, ["S100A7"], 0.061480808449151485, 0, 0], [90, "positive regulation of ERK1 and ERK2 cascade (GO:0070374)", 0.050509180130790456, 23.184795321637427, 69.2205289569504, ["S100A7"], 0.0656619341700276, 0, 0], [91, "defense response to bacterium (GO:0042742)", 0.05165801551321664, 22.650285714285715, 67.11528598348353, ["S100A7"], 0.06641744851699283, 0, 0], [92, "negative regulation of cell differentiation (GO:0045596)", 0.05595583741739159, 20.846315789473685, 60.10394168947767, ["NKX2-1"], 0.07116122801994365, 0, 0], [93, "negative regulation of multicellular organismal process (GO:0051241)", 0.06251430040361035, 18.573708920187794, 51.49300658384643, ["NKX2-1"], 0.07864702308841302, 0, 0], [94, "regulation of ERK1 and ERK2 cascade (GO:0070372)", 0.06931738938855214, 16.672573839662448, 44.500091181655506, ["S100A7"], 0.08627802721766598, 0, 0], [95, "positive regulation of signal transduction (GO:0009967)", 0.07326682369290423, 15.731474103585658, 41.11652611319615, ["IFNB1"], 0.09023387760073469, 0, 0], [96, "central nervous system development (GO:0007417)", 0.07776335159216254, 14.776779026217229, 37.74114992527251, ["NKX2-1"], 0.09477408475294809, 0, 0], [97, "positive regulation of MAPK cascade (GO:0043410)", 0.07944485535766266, 14.447619047619048, 36.59137122245166, ["S100A7"], 0.09582523790563434, 0, 0], [98, "innate immune response (GO:0045087)", 0.0872581320254043, 13.085049833887043, 31.9129254638413, ["S100A7"], 0.10417552496910515, 0, 0], [99, "positive regulation of apoptotic process (GO:0043065)", 0.08948031840285002, 12.741100323624595, 30.753659971516722, ["IFNB1"], 0.10574946720336821, 0, 0], [100, "positive regulation of macromolecule metabolic process (GO:0010604)", 0.10982267971767223, 10.240731070496084, 22.620630189252047, ["NKX2-1"], 0.1284925352696765, 0, 0], [101, "regulation of cell migration (GO:0030334)", 0.11633828630365514, 9.625061425061425, 20.70594294612794, ["NKX2-1"], 0.13476811383690743, 0, 0], [102, "negative regulation of nucleic acid-templated transcription (GO:1903507)", 0.13138696365173613, 8.436717062634989, 17.12323172617443, ["NKX2-1"], 0.1492289500399958, 0, 0], [103, "positive regulation of cell population proliferation (GO:0008284)", 0.13405161943292423, 8.254122621564482, 16.586909784962376, ["EGR4"], 0.1492289500399958, 0, 0], [104, "neutrophil degranulation (GO:0043312)", 0.13591282245621636, 8.130833333333333, 16.22704240839014, ["S100A7"], 0.1492289500399958, 0, 0], [105, "positive regulation of gene expression (GO:0010628)", 0.13617843625530518, 8.113513513513514, 16.176635795129393, ["NKX2-1"], 0.1492289500399958, 0, 0], [106, "cellular response to cytokine stimulus (GO:0071345)", 0.13617843625530518, 8.113513513513514, 16.176635795129393, ["IFNB1"], 0.1492289500399958, 0, 0], [107, "neutrophil activation involved in immune response (GO:0002283)", 0.13697486946968407, 8.061983471074381, 16.026882961137105, ["S100A7"], 0.1492289500399958, 0, 0], [108, "neutrophil mediated immunity (GO:0002446)", 0.13777069069054648, 8.011088295687886, 15.879295928232638, ["S100A7"], 0.1492289500399958, 0, 0], [109, "regulation of transcription, DNA-templated (GO:0006355)", 0.13902526114837216, 3.958965209634255, 7.811432780346923, ["EGR4", "NKX2-1"], 0.1492289500399958, 0, 0], [110, "positive regulation of nucleic acid-templated transcription (GO:1903508)", 0.14385169452323945, 7.64078431372549, 14.815269969426804, ["NKX2-1"], 0.15300589326562744, 0, 0], [111, "negative regulation of cellular macromolecule biosynthetic process (GO:2000113)", 0.15329801811567262, 7.123809523809523, 13.359788791957792, ["NKX2-1"], 0.16158439747327652, 0, 0], [112, "cytokine-mediated signaling pathway (GO:0019221)", 0.17244290587638317, 6.249677419354839, 10.984989739295798, ["IFNB1"], 0.1796078382353798, 0, 0], [113, "positive regulation of cellular process (GO:0048522)", 0.1734673993213497, 6.208333333333333, 10.875544750623106, ["EGR4"], 0.1796078382353798, 0, 0], [114, "negative regulation of transcription by RNA polymerase II (GO:0000122)", 0.18845634920732277, 5.654758418740849, 9.437163376844246, ["NKX2-1"], 0.1934157268180418, 0, 0], [115, "regulation of cell population proliferation (GO:0042127)", 0.20841797228460673, 5.04089121887287, 7.905174674708202, ["EGR4"], 0.21204263267216508, 0, 0], [116, "negative regulation of transcription, DNA-templated (GO:0045892)", 0.25278167769899834, 4.02259767687434, 5.531993369927694, ["NKX2-1"], 0.2549608300929552, 0, 0], [117, "regulation of gene expression (GO:0010468)", 0.2830873472213558, 3.5094619666048237, 4.4289402351621945, ["NKX2-1"], 0.2830873472213558, 0, 0]], [[1, "regulation of growth rate (GO:0040009)", 0.00224816055240216, 624.59375, 3808.549663430724, ["TMPRSS4"], 0.047164363128863705, 0, 0], [2, "sialic acid transport (GO:0015739)", 0.00224816055240216, 624.59375, 3808.549663430724, ["SLC17A4"], 0.047164363128863705, 0, 0], [3, "positive regulation of viral entry into host cell (GO:0046598)", 0.004491844107510829, 277.52777777777777, 1500.1741678966396, ["TMPRSS4"], 0.047164363128863705, 0, 0], [4, "positive regulation by symbiont of entry into host (GO:0075294)", 0.004491844107510829, 277.52777777777777, 1500.1741678966396, ["TMPRSS4"], 0.047164363128863705, 0, 0], [5, "positive regulation of viral life cycle (GO:1903902)", 0.010750337464808102, 108.52173913043478, 491.90930693624915, ["TMPRSS4"], 0.06375157330727682, 0, 0], [6, "positive regulation of leukocyte cell-cell adhesion (GO:1903039)", 0.013866454289070039, 83.17083333333333, 355.82833874131705, ["SIRPG"], 0.06375157330727682, 0, 0], [7, "positive regulation of lymphocyte activation (GO:0051251)", 0.015643173290839224, 73.37132352941177, 305.0574683216414, ["SIRPG"], 0.06375157330727682, 0, 0], [8, "regulation of viral entry into host cell (GO:0046596)", 0.017417046832985512, 65.63486842105263, 265.8412914846341, ["TMPRSS4"], 0.06375157330727682, 0, 0], [9, "regulation of cell-cell adhesion (GO:0022407)", 0.01918807882344009, 59.37202380952381, 234.72528267100722, ["SIRPG"], 0.06375157330727682, 0, 0], [10, "anion transport (GO:0006820)", 0.01918807882344009, 59.37202380952381, 234.72528267100722, ["SLC17A4"], 0.06375157330727682, 0, 0], [11, "positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862)", 0.02095627318649442, 54.19836956521739, 209.49389233222107, ["BMP3"], 0.06375157330727682, 0, 0], [12, "regulation of T cell activation (GO:0050863)", 0.02095627318649442, 54.19836956521739, 209.49389233222107, ["SIRPG"], 0.06375157330727682, 0, 0], [13, "positive regulation of cell-cell adhesion (GO:0022409)", 0.02095627318649442, 54.19836956521739, 209.49389233222107, ["SIRPG"], 0.06375157330727682, 0, 0], [14, "positive regulation of phagocytosis (GO:0050766)", 0.023603252767760232, 47.93028846153846, 179.56463060223416, ["SIRPG"], 0.06375157330727682, 0, 0], [15, "carboxylic acid transport (GO:0046942)", 0.025364370254955197, 44.497767857142854, 163.5030358762894, ["SLC17A4"], 0.06375157330727682, 0, 0], [16, "regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393)", 0.02580420824342157, 43.71491228070175, 159.87495051613905, ["BMP3"], 0.06375157330727682, 0, 0], [17, "regulation of phagocytosis (GO:0050764)", 0.02580420824342157, 43.71491228070175, 159.87495051613905, ["SIRPG"], 0.06375157330727682, 0, 0], [18, "positive regulation of T cell activation (GO:0050870)", 0.03325451045778232, 33.64358108108108, 114.5081106084989, ["SIRPG"], 0.07759385773482542, 0, 0], [19, "positive regulation of cell adhesion (GO:0045785)", 0.03543611612294145, 31.50632911392405, 105.23188749884586, ["SIRPG"], 0.07761242296639746, 0, 0], [20, "sodium ion transport (GO:0006814)", 0.039786204244047274, 27.952247191011235, 90.12461522615385, ["SLC17A4"], 0.07761242296639746, 0, 0], [21, "positive regulation of transport (GO:0051050)", 0.04022025247919156, 27.64027777777778, 88.81884342634399, ["SIRPG"], 0.07761242296639746, 0, 0], [22, "positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100)", 0.040654126315732, 27.335164835164836, 87.54510068843584, ["BMP3"], 0.07761242296639746, 0, 0], [23, "protein maturation (GO:0051604)", 0.04282088157064431, 25.904947916666668, 81.61948121913939, ["TMPRSS4"], 0.07819465330291568, 0, 0], [24, "protein processing (GO:0016485)", 0.046710081786484385, 23.673809523809524, 72.5317052519737, ["TMPRSS4"], 0.08174264312634767, 0, 0], [25, "ion transport (GO:0006811)", 0.051014935889860884, 21.604347826086958, 64.2866930480565, ["SLC17A4"], 0.08570509229496628, 0, 0], [26, "negative regulation of growth (GO:0045926)", 0.05530250201455211, 19.866, 57.51082096679438, ["TMPRSS4"], 0.08933481094658419, 0, 0], [27, "enzyme linked receptor protein signaling pathway (GO:0007167)", 0.06127616634057289, 17.85251798561151, 49.85073415990269, ["ANGPTL1"], 0.09531848097422449, 0, 0], [28, "skeletal system development (GO:0001501)", 0.06890724443039566, 15.79140127388535, 42.24190306488084, ["BMP3"], 0.10336086664559349, 0, 0], [29, "cation transport (GO:0006812)", 0.07564408105928605, 14.31936416184971, 36.968532753958556, ["SLC17A4"], 0.1095534967065522, 0, 0], [30, "regulation of macromolecule metabolic process (GO:0060255)", 0.08649906605727922, 12.4321608040201, 30.429226090981548, ["TMPRSS4"], 0.12109869248019091, 0, 0], [31, "phosphate-containing compound metabolic process (GO:0006796)", 0.0914707296716085, 11.718009478672986, 28.02638807349727, ["SLC17A4"], 0.1239280853615341, 0, 0], [32, "proteolysis (GO:0006508)", 0.12200241335360172, 8.612325174825175, 18.117872942989372, ["TMPRSS4"], 0.16012816752660225, 0, 0], [33, "positive regulation of protein phosphorylation (GO:0001934)", 0.1551122195058613, 6.628716216216216, 12.353318144692642, ["BMP3"], 0.19543203004367343, 0, 0], [34, "negative regulation of cell population proliferation (GO:0008285)", 0.1582068814639261, 6.485780423280423, 11.958817428486013, ["SIRPG"], 0.19543203004367343, 0, 0], [35, "transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)", 0.16781286387234287, 6.075682382133995, 10.844520880520044, ["ANGPTL1"], 0.20137543664681143, 0, 0], [36, "positive regulation of cell population proliferation (GO:0008284)", 0.19419335631720047, 5.158033826638478, 8.453506457263389, ["SIRPG"], 0.22655891570340056, 0, 0], [37, "negative regulation of cellular process (GO:0048523)", 0.22773331955334702, 4.297787610619469, 6.358920531398367, ["SIRPG"], 0.25850809246596146, 0, 0], [38, "positive regulation of cellular process (GO:0048522)", 0.24858393121402697, 3.879607371794872, 5.400315459189092, ["SIRPG"], 0.27475066081550353, 0, 0], [39, "regulation of cell population proliferation (GO:0042127)", 0.29574133486516935, 3.1500655307994756, 3.8376305717304233, ["SIRPG"], 0.3184906683163362, 0, 0], [40, "regulation of gene expression (GO:0010468)", 0.3930084885087277, 2.19306586270872, 2.048156992084284, ["TMPRSS4"], 0.4126589129341641, 0, 0], [41, "regulation of transcription by RNA polymerase II (GO:0006357)", 0.6507822338118429, 1.0082766439909296, 0.4331356854141271, ["ONECUT3"], 0.657438598129094, 0, 0], [42, "regulation of transcription, DNA-templated (GO:0006355)", 0.657438598129094, 0.9890771288452965, 0.414822811338105, ["ONECUT3"], 0.657438598129094, 0, 0]]], "spearman": [[[1, "positive regulation of cell-substrate adhesion (GO:0010811)", 0.0007791063560372328, 58.588235294117645, 419.3372670889321, ["CDH13", "OLFM4"], 0.03649187799249512, 0, 0], [2, "regulation of vesicle-mediated transport (GO:0060627)", 0.0014584201472092786, 42.327659574468086, 276.41661242727787, ["CDH13", "OLFM4"], 0.03649187799249512, 0, 0], [3, "defense response to symbiont (GO:0140546)", 0.0024163697244848196, 32.5672131147541, 196.23338369839547, ["IFNL2", "IFNL1"], 0.03649187799249512, 0, 0], [4, "defense response to virus (GO:0051607)", 0.0027730648199082307, 30.316030534351146, 178.4947893730614, ["IFNL2", "IFNL1"], 0.03649187799249512, 0, 0], [5, "negative regulation of interleukin-13 production (GO:0032696)", 0.002996653029893649, 454.1818181818182, 2638.914119276588, ["IFNL1"], 0.03649187799249512, 0, 0], [6, "negative regulation of interleukin-5 production (GO:0032714)", 0.002996653029893649, 454.1818181818182, 2638.914119276588, ["IFNL1"], 0.03649187799249512, 0, 0], [7, "negative regulation of blood coagulation, intrinsic pathway (GO:2000267)", 0.002996653029893649, 454.1818181818182, 2638.914119276588, ["A2M"], 0.03649187799249512, 0, 0], [8, "positive regulation of MHC class I biosynthetic process (GO:0045345)", 0.002996653029893649, 454.1818181818182, 2638.914119276588, ["IFNL1"], 0.03649187799249512, 0, 0], [9, "regulation of blood coagulation, intrinsic pathway (GO:2000266)", 0.002996653029893649, 454.1818181818182, 2638.914119276588, ["A2M"], 0.03649187799249512, 0, 0], [10, "regulation of neutrophil extravasation (GO:2000389)", 0.0035949984464796287, 363.3272727272727, 2044.8828145385057, ["OLFM4"], 0.03649187799249512, 0, 0], [11, "regulation of type 2 immune response (GO:0002828)", 0.0035949984464796287, 363.3272727272727, 2044.8828145385057, ["IFNL1"], 0.03649187799249512, 0, 0], [12, "keratinocyte proliferation (GO:0043616)", 0.0041930151049605156, 302.75757575757575, 1657.3964565725007, ["CDH13"], 0.03649187799249512, 0, 0], [13, "negative regulation of lymphocyte differentiation (GO:0045620)", 0.0041930151049605156, 302.75757575757575, 1657.3964565725007, ["IFNL1"], 0.03649187799249512, 0, 0], [14, "regulation of necrotic cell death (GO:0010939)", 0.0041930151049605156, 302.75757575757575, 1657.3964565725007, ["OLFM4"], 0.03649187799249512, 0, 0], [15, "negative regulation of type 2 immune response (GO:0002829)", 0.0041930151049605156, 302.75757575757575, 1657.3964565725007, ["IFNL1"], 0.03649187799249512, 0, 0], [16, "regulation of MHC class I biosynthetic process (GO:0045343)", 0.0041930151049605156, 302.75757575757575, 1657.3964565725007, ["IFNL1"], 0.03649187799249512, 0, 0], [17, "sequestering of BMP from receptor via BMP binding (GO:0038098)", 0.00479070309341298, 259.4935064935065, 1385.975083259077, ["CHRDL1"], 0.03649187799249512, 0, 0], [18, "regulation of positive chemotaxis (GO:0050926)", 0.00479070309341298, 259.4935064935065, 1385.975083259077, ["CDH13"], 0.03649187799249512, 0, 0], [19, "positive regulation of endocytic recycling (GO:2001137)", 0.00479070309341298, 259.4935064935065, 1385.975083259077, ["PLA2G4E"], 0.03649187799249512, 0, 0], [20, "regulation of cellular extravasation (GO:0002691)", 0.0053880625223818295, 227.04545454545453, 1185.9876925180256, ["OLFM4"], 0.03649187799249512, 0, 0], [21, "negative regulation of protein activation cascade (GO:2000258)", 0.0053880625223818295, 227.04545454545453, 1185.9876925180256, ["A2M"], 0.03649187799249512, 0, 0], [22, "N-acylphosphatidylethanolamine metabolic process (GO:0070292)", 0.0053880625223818295, 227.04545454545453, 1185.9876925180256, ["PLA2G4E"], 0.03649187799249512, 0, 0], [23, "regulation of neutrophil migration (GO:1902622)", 0.00598509351248777, 201.8080808080808, 1032.9512945731403, ["OLFM4"], 0.037157455556694904, 0, 0], [24, "regulation of memory T cell differentiation (GO:0043380)", 0.00598509351248777, 201.8080808080808, 1032.9512945731403, ["IFNL1"], 0.037157455556694904, 0, 0], [25, "regulation of endocytic recycling (GO:2001135)", 0.006581796197874835, 181.61818181818182, 912.3494182081016, ["PLA2G4E"], 0.039227505339334015, 0, 0], [26, "negative regulation of complement activation (GO:0045916)", 0.007178170714881846, 165.099173553719, 815.046857216495, ["A2M"], 0.040229691526464245, 0, 0], [27, "positive regulation of calcium-mediated signaling (GO:0050850)", 0.007774217207607984, 151.33333333333334, 735.0172993440868, ["CDH13"], 0.040229691526464245, 0, 0], [28, "regulation of interleukin-5 production (GO:0032674)", 0.007774217207607984, 151.33333333333334, 735.0172993440868, ["IFNL1"], 0.040229691526464245, 0, 0], [29, "sequestering of extracellular ligand from receptor (GO:0035581)", 0.008369935820942226, 139.6853146853147, 668.1300945358273, ["CHRDL1"], 0.040229691526464245, 0, 0], [30, "cellular response to low-density lipoprotein particle stimulus (GO:0071404)", 0.008369935820942226, 139.6853146853147, 668.1300945358273, ["CDH13"], 0.040229691526464245, 0, 0], [31, "negative regulation of T cell differentiation (GO:0045581)", 0.008369935820942226, 139.6853146853147, 668.1300945358273, ["IFNL1"], 0.040229691526464245, 0, 0], [32, "negative regulation of immune effector process (GO:0002698)", 0.00956039001281181, 121.04848484848485, 562.8907982194623, ["IFNL1"], 0.04189700329144, 0, 0], [33, "regulation of interleukin-13 production (GO:0032656)", 0.00956039001281181, 121.04848484848485, 562.8907982194623, ["IFNL1"], 0.04189700329144, 0, 0], [34, "regulation of ERBB signaling pathway (GO:1901184)", 0.00956039001281181, 121.04848484848485, 562.8907982194623, ["CDH13"], 0.04189700329144, 0, 0], [35, "positive regulation of positive chemotaxis (GO:0050927)", 0.010155125895608219, 113.47727272727273, 520.8353408254836, ["CDH13"], 0.043231821669874985, 0, 0], [36, "hyaluronan catabolic process (GO:0030214)", 0.010749534506708167, 106.79679144385027, 484.0984098875249, ["HYAL4"], 0.04328866598647343, 0, 0], [37, "phosphatidylinositol acyl-chain remodeling (GO:0036149)", 0.010749534506708167, 106.79679144385027, 484.0984098875249, ["PLA2G4E"], 0.04328866598647343, 0, 0], [38, "Rac protein signal transduction (GO:0016601)", 0.011343616002547938, 100.85858585858585, 451.7557080600296, ["CDH13"], 0.04333843036870879, 0, 0], [39, "glycerolipid catabolic process (GO:0046503)", 0.011343616002547938, 100.85858585858585, 451.7557080600296, ["PLA2G4E"], 0.04333843036870879, 0, 0], [40, "positive regulation of immune system process (GO:0002684)", 0.012530798277531565, 90.76363636363637, 397.50531795625653, ["IFNL1"], 0.04667722358380508, 0, 0], [41, "phosphatidylserine acyl-chain remodeling (GO:0036150)", 0.013123899368825872, 86.43722943722943, 374.56020373045595, ["PLA2G4E"], 0.047529870290991975, 0, 0], [42, "innate immune response (GO:0045087)", 0.013572683267541302, 13.125333333333334, 56.43494440563777, ["IFNL2", "IFNL1"], 0.047529870290991975, 0, 0], [43, "hyaluronan metabolic process (GO:0030212)", 0.013716673976595, 82.50413223140495, 353.872030109198, ["HYAL4"], 0.047529870290991975, 0, 0], [44, "phospholipid catabolic process (GO:0009395)", 0.014309122256811026, 78.91304347826087, 335.1324919763037, ["PLA2G4E"], 0.04845589127874643, 0, 0], [45, "lamellipodium assembly (GO:0030032)", 0.015493040473318351, 72.59272727272727, 302.5203442580517, ["CDH13"], 0.05018397892444423, 0, 0], [46, "phosphatidylethanolamine acyl-chain remodeling (GO:0036152)", 0.015493040473318351, 72.59272727272727, 302.5203442580517, ["PLA2G4E"], 0.05018397892444423, 0, 0], [47, "mucosal immune response (GO:0002385)", 0.01667565529767051, 67.20875420875421, 275.1395602176083, ["IFNL2"], 0.050707604884753184, 0, 0], [48, "glycerophospholipid catabolic process (GO:0046475)", 0.01667565529767051, 67.20875420875421, 275.1395602176083, ["PLA2G4E"], 0.050707604884753184, 0, 0], [49, "regulation of calcium-mediated signaling (GO:0050848)", 0.01667565529767051, 67.20875420875421, 275.1395602176083, ["CDH13"], 0.050707604884753184, 0, 0], [50, "lamellipodium organization (GO:0097581)", 0.017266474337105393, 64.8051948051948, 263.043544162992, ["CDH13"], 0.05145409352457407, 0, 0], [51, "phosphatidylcholine acyl-chain remodeling (GO:0036151)", 0.017856968008938604, 62.56739811912226, 251.8563944353508, ["PLA2G4E"], 0.05186081762570235, 0, 0], [52, "aminoglycan catabolic process (GO:0006026)", 0.018447136470887412, 60.47878787878788, 241.48249384895686, ["HYAL4"], 0.05186081762570235, 0, 0], [53, "phosphatidylethanolamine metabolic process (GO:0046337)", 0.018447136470887412, 60.47878787878788, 241.48249384895686, ["PLA2G4E"], 0.05186081762570235, 0, 0], [54, "positive regulation of receptor signaling pathway via STAT (GO:1904894)", 0.019036979887302796, 58.52492668621701, 231.83899894541258, ["IFNL1"], 0.052527963022372524, 0, 0], [55, "positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427)", 0.01962649841488355, 56.69318181818182, 222.85379213708367, ["IFNL1"], 0.053169968433048165, 0, 0], [56, "phosphatidylserine metabolic process (GO:0006658)", 0.020215692219209058, 54.972451790633606, 214.4638136267328, ["PLA2G4E"], 0.053788181083252666, 0, 0], [57, "negative regulation of cell population proliferation (GO:0008285)", 0.02084945120044108, 10.403713527851458, 40.26682052590156, ["IFNL1", "CDH13"], 0.05402665825304592, 0, 0], [58, "calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339)", 0.021393106288118857, 51.82597402597403, 199.25462501506232, ["CDH13"], 0.05402665825304592, 0, 0], [59, "positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)", 0.021393106288118857, 51.82597402597403, 199.25462501506232, ["OLFM4"], 0.05402665825304592, 0, 0], [60, "negative regulation of innate immune response (GO:0045824)", 0.02256922338610946, 49.01965601965602, 185.84175607013447, ["A2M"], 0.05476766031287691, 0, 0], [61, "positive regulation of intracellular transport (GO:0032388)", 0.02315679597121641, 47.72727272727273, 179.71546945510647, ["PLA2G4E"], 0.05476766031287691, 0, 0], [62, "regulation of T cell differentiation (GO:0045580)", 0.02315679597121641, 47.72727272727273, 179.71546945510647, ["IFNL1"], 0.05476766031287691, 0, 0], [63, "endothelial cell migration (GO:0043542)", 0.02315679597121641, 47.72727272727273, 179.71546945510647, ["CDH13"], 0.05476766031287691, 0, 0], [64, "negative regulation of blood coagulation (GO:0030195)", 0.02374404479036207, 46.5011655011655, 173.93405340895535, ["A2M"], 0.05492900806916125, 0, 0], [65, "epithelial cell migration (GO:0010631)", 0.024330970017212364, 45.336363636363636, 168.47016546086343, ["CDH13"], 0.05492900806916125, 0, 0], [66, "visual system development (GO:0150063)", 0.024330970017212364, 45.336363636363636, 168.47016546086343, ["CHRDL1"], 0.05492900806916125, 0, 0], [67, "positive regulation of cell-matrix adhesion (GO:0001954)", 0.026089805695170006, 42.167019027484145, 153.74983290143678, ["CDH13"], 0.05641460301136417, 0, 0], [68, "regulation of receptor signaling pathway via JAK-STAT (GO:0046425)", 0.026675438127783887, 41.20661157024794, 149.33325716982057, ["IFNL1"], 0.05641460301136417, 0, 0], [69, "negative regulation of T cell activation (GO:0050868)", 0.026675438127783887, 41.20661157024794, 149.33325716982057, ["IFNL1"], 0.05641460301136417, 0, 0], [70, "positive regulation of chemotaxis (GO:0050921)", 0.026675438127783887, 41.20661157024794, 149.33325716982057, ["CDH13"], 0.05641460301136417, 0, 0], [71, "positive regulation of response to stimulus (GO:0048584)", 0.02726074776388067, 40.28888888888889, 145.1329634798573, ["IFNL1"], 0.05641460301136417, 0, 0], [72, "positive regulation of smooth muscle cell proliferation (GO:0048661)", 0.02726074776388067, 40.28888888888889, 145.1329634798573, ["CDH13"], 0.05641460301136417, 0, 0], [73, "adherens junction organization (GO:0034332)", 0.029014741507151904, 37.765151515151516, 133.68679532449664, ["CDH13"], 0.05842157411575181, 0, 0], [74, "regulation of smooth muscle cell proliferation (GO:0048660)", 0.029014741507151904, 37.765151515151516, 133.68679532449664, ["CDH13"], 0.05842157411575181, 0, 0], [75, "positive regulation of cell morphogenesis involved in differentiation (GO:0010770)", 0.029598761568907096, 36.99257884972171, 130.2147194065139, ["OLFM4"], 0.05877063520256545, 0, 0], [76, "regulation of substrate adhesion-dependent cell spreading (GO:1900024)", 0.030182459639590885, 36.25090909090909, 126.89610172901739, ["OLFM4"], 0.05877063520256545, 0, 0], [77, "negative regulation of BMP signaling pathway (GO:0030514)", 0.030765835877853052, 35.53832442067736, 123.7213609818225, ["CHRDL1"], 0.05877063520256545, 0, 0], [78, "sprouting angiogenesis (GO:0002040)", 0.030765835877853052, 35.53832442067736, 123.7213609818225, ["CDH13"], 0.05877063520256545, 0, 0], [79, "glycosaminoglycan metabolic process (GO:0030203)", 0.03193162350337226, 34.19382504288165, 117.76895070161899, ["HYAL4"], 0.05935630505096695, 0, 0], [80, "cellular response to cytokine stimulus (GO:0071345)", 0.032604577769221134, 8.128333333333334, 27.825744455648255, ["IFNL2", "IFNL1"], 0.05935630505096695, 0, 0], [81, "glycosaminoglycan catabolic process (GO:0006027)", 0.03309612573679984, 32.94710743801653, 112.2949128878184, ["HYAL4"], 0.05935630505096695, 0, 0], [82, "Rho protein signal transduction (GO:0007266)", 0.03309612573679984, 32.94710743801653, 112.2949128878184, ["CDH13"], 0.05935630505096695, 0, 0], [83, "sensory organ development (GO:0007423)", 0.03309612573679984, 32.94710743801653, 112.2949128878184, ["CHRDL1"], 0.05935630505096695, 0, 0], [84, "positive regulation of interferon-gamma production (GO:0032729)", 0.03367789522880521, 32.357142857142854, 109.72027527854156, ["IFNL1"], 0.05935630505096695, 0, 0], [85, "eye development (GO:0001654)", 0.03425934385492052, 31.78787878787879, 107.24581633848625, ["CHRDL1"], 0.05935630505096695, 0, 0], [86, "regulation of phagocytosis (GO:0050764)", 0.03425934385492052, 31.78787878787879, 107.24581633848625, ["OLFM4"], 0.05935630505096695, 0, 0], [87, "positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)", 0.034840471769761905, 31.238244514106583, 104.86602418496526, ["IFNL1"], 0.05966931372062671, 0, 0], [88, "homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)", 0.035421279144613474, 30.70724191063174, 102.57577696947945, ["CDH13"], 0.059974665824402355, 0, 0], [89, "regulation of endocytosis (GO:0030100)", 0.03600176612865679, 30.193939393939395, 100.37030934492944, ["CDH13"], 0.060272619698537776, 0, 0], [90, "antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)", 0.037741306359582505, 28.751803751803752, 94.21966448632159, ["CXCL14"], 0.06232269598711797, 0, 0], [91, "regulation of cell-matrix adhesion (GO:0001952)", 0.038320513395665175, 28.301136363636363, 92.31179552985674, ["CDH13"], 0.06232269598711797, 0, 0], [92, "extracellular matrix disassembly (GO:0022617)", 0.03889940085101994, 27.864335664335666, 90.46926829385504, ["A2M"], 0.06232269598711797, 0, 0], [93, "cellular component disassembly (GO:0022411)", 0.03889940085101994, 27.864335664335666, 90.46926829385504, ["A2M"], 0.06232269598711797, 0, 0], [94, "regulation of epidermal growth factor receptor signaling pathway (GO:0042058)", 0.039477968873990896, 27.44077134986226, 88.6889163609223, ["CDH13"], 0.06257678044919833, 0, 0], [95, "regulation of tyrosine phosphorylation of STAT protein (GO:0042509)", 0.040056217631282115, 27.029850746268657, 86.96777093294467, ["IFNL1"], 0.0628250150216951, 0, 0], [96, "negative regulation of cell adhesion (GO:0007162)", 0.042942678013426154, 25.146464646464647, 79.15828251915687, ["CDH13"], 0.0666506148333385, 0, 0], [97, "negative regulation of cellular process (GO:0048523)", 0.043734808326550065, 6.887943262411348, 21.556582758480396, ["IFNL1", "CDH13"], 0.06674922034548711, 0, 0], [98, "positive regulation of immune response (GO:0050778)", 0.04409503288389166, 24.464373464373466, 76.36329437117712, ["IFNL1"], 0.06674922034548711, 0, 0], [99, "phospholipid metabolic process (GO:0006644)", 0.04467073326473782, 24.136969696969697, 75.02824312324114, ["PLA2G4E"], 0.06674922034548711, 0, 0], [100, "phosphatidylcholine metabolic process (GO:0046470)", 0.04524611580465905, 23.818181818181817, 73.7324794714548, ["PLA2G4E"], 0.06674922034548711, 0, 0], [101, "positive regulation of endothelial cell proliferation (GO:0001938)", 0.04524611580465905, 23.818181818181817, 73.7324794714548, ["CDH13"], 0.06674922034548711, 0, 0], [102, "glycerophospholipid metabolic process (GO:0006650)", 0.04697035804559035, 22.9102416570771, 70.06498436559322, ["PLA2G4E"], 0.06861356224306825, 0, 0], [103, "cell-cell junction organization (GO:0045216)", 0.04811826663840212, 22.342312008978677, 67.78866163441084, ["CDH13"], 0.06960797795263997, 0, 0], [104, "regulation of interferon-gamma production (GO:0032649)", 0.05041028257884421, 21.28663101604278, 63.595089599609956, ["IFNL1"], 0.07222242407930565, 0, 0], [105, "cytokine-mediated signaling pathway (GO:0019221)", 0.051702535837496774, 6.258158319870759, 18.538219780322443, ["IFNL2", "IFNL1"], 0.073368360378924, 0, 0], [106, "regulation of endothelial cell proliferation (GO:0001936)", 0.05383882244884977, 19.877122877122876, 58.07619178413111, ["CDH13"], 0.07567909947998694, 0, 0], [107, "regulation of cell death (GO:0010941)", 0.059527849199832554, 17.900090009000902, 50.50172123995827, ["OLFM4"], 0.08289392084836496, 0, 0], [108, "phosphatidylinositol metabolic process (GO:0046488)", 0.06518550479553244, 16.27927927927928, 44.450867603715174, ["PLA2G4E"], 0.08993185383828085, 0, 0], [109, "cellular amide metabolic process (GO:0043603)", 0.06687670762493306, 15.848484848484848, 42.86863861107806, ["PLA2G4E"], 0.09141861867995436, 0, 0], [110, "positive regulation of epithelial cell proliferation (GO:0050679)", 0.07137287991941299, 14.80327868852459, 39.07824746413377, ["CDH13"], 0.09667781007265941, 0, 0], [111, "platelet degranulation (GO:0002576)", 0.07249381569444491, 14.563049853372434, 38.21714214339772, ["A2M"], 0.09731151836461524, 0, 0], [112, "regulation of cell population proliferation (GO:0042127)", 0.07465128685434329, 5.046194225721785, 13.094508250641674, ["IFNL1", "CDH13"], 0.09854038156732244, 0, 0], [113, "positive regulation of macromolecule biosynthetic process (GO:0010557)", 0.07473196722890896, 14.105113636363637, 36.58651144234639, ["IFNL1"], 0.09854038156732244, 0, 0], [114, "regulation of cell adhesion (GO:0030155)", 0.07696516706764417, 13.674931129476583, 35.06802532248599, ["CDH13"], 0.10044244763977078, 0, 0], [115, "positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)", 0.0775226944870714, 13.571428571428571, 34.70464751040876, ["IFNL1"], 0.10044244763977078, 0, 0], [116, "regulation of cellular component organization (GO:0051128)", 0.08030570414317773, 13.076416337285902, 32.97760560549118, ["CDH13"], 0.10315129239080588, 0, 0], [117, "regulation of small GTPase mediated signal transduction (GO:0051056)", 0.08141675143721483, 12.888311688311688, 32.32613131615323, ["A2M"], 0.10350678154986107, 0, 0], [118, "Ras protein signal transduction (GO:0007265)", 0.08197181357640004, 12.796260477111542, 32.008307827212725, ["CDH13"], 0.10350678154986107, 0, 0], [119, "cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)", 0.09738928736005688, 10.661108122646585, 24.830137244993452, ["CDH13"], 0.1219412085432645, 0, 0], [120, "negative regulation of immune response (GO:0050777)", 0.10175047824033288, 10.175141242937853, 23.252555875085513, ["IFNL1"], 0.12559692854058374, 0, 0], [121, "regulation of immune response (GO:0050776)", 0.10229426679107169, 10.117466802860061, 23.06682926467287, ["IFNL1"], 0.12559692854058374, 0, 0], [122, "regulated exocytosis (GO:0045055)", 0.10283775357014241, 10.060436769933977, 22.883497050073817, ["A2M"], 0.12559692854058374, 0, 0], [123, "negative regulation of cytokine production (GO:0001818)", 0.10392382237785831, 9.948267202410848, 22.52384317538298, ["IFNL1"], 0.12589145962846252, 0, 0], [124, "regulation of programmed cell death (GO:0043067)", 0.1104149663820142, 9.324069712670749, 20.545677022917864, ["OLFM4"], 0.13267604831387192, 0, 0], [125, "phosphate-containing compound metabolic process (GO:0006796)", 0.12007089711947924, 8.520896165445928, 18.061512696944295, ["PLA2G4E"], 0.14312450936641924, 0, 0], [126, "positive regulation of cell motility (GO:2000147)", 0.1248627470990637, 8.168595041322314, 16.99509010087468, ["CDH13"], 0.14765515331555945, 0, 0], [127, "positive regulation of cell migration (GO:0030335)", 0.15001775039031348, 6.689280868385346, 12.689576884452375, ["CDH13"], 0.17600507722958036, 0, 0], [128, "plasma membrane bounded cell projection assembly (GO:0120031)", 0.15465986057932218, 6.468985887758451, 12.074536959698023, ["CDH13"], 0.18003374395561722, 0, 0], [129, "positive regulation of transcription, DNA-templated (GO:0045893)", 0.15589083664952325, 3.1849280270956815, 5.919504943584241, ["IFNL1", "CDH13"], 0.18005995861068966, 0, 0], [130, "extracellular matrix organization (GO:0030198)", 0.16590957450841412, 5.986318029796291, 10.753297133202047, ["A2M"], 0.19015789693656693, 0, 0], [131, "positive regulation of cytokine production (GO:0001819)", 0.18352431992317214, 5.349482852476864, 9.069556487367386, ["IFNL1"], 0.20874140205002023, 0, 0], [132, "post-translational protein modification (GO:0043687)", 0.18849409594421104, 5.191331923890063, 8.662716368209253, ["CHRDL1"], 0.2127698507249049, 0, 0], [133, "regulation of cell migration (GO:0030334)", 0.21917141641280938, 4.373687737324101, 6.638825567444713, ["CDH13"], 0.245537902597809, 0, 0], [134, "cellular protein metabolic process (GO:0044267)", 0.2234660366325064, 4.2770979020979025, 6.409213404377618, ["CHRDL1"], 0.24848089147942873, 0, 0], [135, "regulation of intracellular signal transduction (GO:1902531)", 0.23293222567035762, 4.076730608840701, 5.939828070057347, ["A2M"], 0.2570881601843206, 0, 0], [136, "negative regulation of nucleic acid-templated transcription (GO:1903507)", 0.24554381708103362, 3.833693304535637, 5.383578322629747, ["IFNL1"], 0.26901491724319126, 0, 0], [137, "positive regulation of cell population proliferation (GO:0008284)", 0.2501663356311247, 3.750720738035749, 5.197108325087597, ["CDH13"], 0.2720787153944349, 0, 0], [138, "neutrophil degranulation (GO:0043312)", 0.25338663554284113, 3.69469696969697, 5.072223180750502, ["OLFM4"], 0.273089598109254, 0, 0], [139, "neutrophil activation involved in immune response (GO:0002283)", 0.2552211099302061, 3.663410969196093, 5.002845647927838, ["OLFM4"], 0.273089598109254, 0, 0], [140, "neutrophil mediated immunity (GO:0002446)", 0.2565942532570172, 3.6402837408997573, 4.951729532081089, ["OLFM4"], 0.273089598109254, 0, 0], [141, "positive regulation of nucleic acid-templated transcription (GO:1903508)", 0.26704483779082666, 3.4720142602495545, 4.584234804758777, ["IFNL1"], 0.28219631794917144, 0, 0], [142, "positive regulation of intracellular signal transduction (GO:1902533)", 0.28268973579756657, 3.2432026688907425, 4.097479514461909, ["CDH13"], 0.29501187334192785, 0, 0], [143, "negative regulation of cellular macromolecule biosynthetic process (GO:2000113)", 0.28313220058990396, 3.237096237096237, 4.0847018875843455, ["IFNL1"], 0.29501187334192785, 0, 0], [144, "regulation of apoptotic process (GO:0042981)", 0.36478700556273874, 2.3613053613053614, 2.3812386561312207, ["OLFM4"], 0.3774532210336672, 0, 0], [145, "positive regulation of transcription by RNA polymerase II (GO:0045944)", 0.4274816321367295, 1.9124987471183723, 1.6253255035640346, ["CDH13"], 0.43927422888532897, 0, 0], [146, "negative regulation of transcription, DNA-templated (GO:0045892)", 0.4417148744162054, 1.8278775079197465, 1.493541686074466, ["IFNL1"], 0.45079120745215484, 0, 0], [147, "cellular protein modification process (GO:0006464)", 0.46820465573063685, 1.68359375, 1.2775947469347737, ["CHRDL1"], 0.4745747871011217, 0, 0], [148, "regulation of transcription by RNA polymerase II (GO:0006357)", 0.754106540246353, 0.7331684188827046, 0.2069159795658213, ["CDH13"], 0.759201854707477, 0, 0], [149, "regulation of transcription, DNA-templated (GO:0006355)", 0.7603363385910282, 0.7192072305759332, 0.19705874845398563, ["IFNL1"], 0.7603363385910282, 0, 0]], [[1, "lung morphogenesis (GO:0060425)", 0.0014992198216206949, 999.5, 6499.5590198897235, ["NKX2-1"], 0.028448319415720673, 0, 0], [2, "positive regulation of transcription by RNA polymerase II (GO:0045944)", 0.001682410756738403, 21.09281767955801, 134.73095382246856, ["EGR4", "IFNB1", "NKX2-1"], 0.028448319415720673, 0, 0], [3, "epithelial tube branching involved in lung morphogenesis (GO:0060441)", 0.00179884089014784, 799.56, 5053.709147518722, ["NKX2-1"], 0.028448319415720673, 0, 0], [4, "regulation of macromolecule biosynthetic process (GO:0010556)", 0.00179884089014784, 799.56, 5053.709147518722, ["IFNB1"], 0.028448319415720673, 0, 0], [5, "negative regulation of lymphocyte differentiation (GO:0045620)", 0.002098387281973246, 666.2666666666667, 4108.590825691207, ["IFNB1"], 0.028448319415720673, 0, 0], [6, "negative regulation of type 2 immune response (GO:0002829)", 0.002098387281973246, 666.2666666666667, 4108.590825691207, ["IFNB1"], 0.028448319415720673, 0, 0], [7, "regulation of MHC class I biosynthetic process (GO:0045343)", 0.002098387281973246, 666.2666666666667, 4108.590825691207, ["IFNB1"], 0.028448319415720673, 0, 0], [8, "thyroid gland development (GO:0030878)", 0.002397858969227747, 571.0571428571428, 3445.2899826083253, ["NKX2-1"], 0.028448319415720673, 0, 0], [9, "negative regulation of T cell cytokine production (GO:0002725)", 0.0026972559359141816, 499.65, 2955.689739283532, ["IFNB1"], 0.028448319415720673, 0, 0], [10, "positive regulation of circadian rhythm (GO:0042753)", 0.002996578172872153, 444.1111111111111, 2580.4117942926405, ["NKX2-1"], 0.028448319415720673, 0, 0], [11, "regulation of T-helper 2 cell cytokine production (GO:2000551)", 0.0032958256764104633, 399.68, 2284.210591570385, ["IFNB1"], 0.028448319415720673, 0, 0], [12, "positive regulation of transcription, DNA-templated (GO:0045893)", 0.003606272382420998, 15.94406779661017, 89.6866667852248, ["EGR4", "IFNB1", "NKX2-1"], 0.028448319415720673, 0, 0], [13, "negative regulation of T cell differentiation (GO:0045581)", 0.004193119798694676, 307.4, 1682.8029678019434, ["IFNB1"], 0.028448319415720673, 0, 0], [14, "positive regulation of T cell chemotaxis (GO:0010820)", 0.004193119798694676, 307.4, 1682.8029678019434, ["S100A7"], 0.028448319415720673, 0, 0], [15, "cellular response to exogenous dsRNA (GO:0071360)", 0.004492068393214533, 285.42857142857144, 1542.8675927558304, ["IFNB1"], 0.028448319415720673, 0, 0], [16, "regulation of T cell chemotaxis (GO:0010819)", 0.004492068393214533, 285.42857142857144, 1542.8675927558304, ["S100A7"], 0.028448319415720673, 0, 0], [17, "B cell activation involved in immune response (GO:0002312)", 0.004790942275014269, 266.38666666666666, 1422.7786907214238, ["IFNB1"], 0.028448319415720673, 0, 0], [18, "positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141)", 0.0053884659389882355, 235.0235294117647, 1227.644124299904, ["IFNB1"], 0.028448319415720673, 0, 0], [19, "positive regulation of lymphocyte chemotaxis (GO:0140131)", 0.0053884659389882355, 235.0235294117647, 1227.644124299904, ["S100A7"], 0.028448319415720673, 0, 0], [20, "cellular response to dsRNA (GO:0071359)", 0.0053884659389882355, 235.0235294117647, 1227.644124299904, ["IFNB1"], 0.028448319415720673, 0, 0], [21, "regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139)", 0.005687115738983334, 221.95555555555555, 1147.4107993095174, ["IFNB1"], 0.028448319415720673, 0, 0], [22, "positive regulation of monocyte chemotaxis (GO:0090026)", 0.005687115738983334, 221.95555555555555, 1147.4107993095174, ["S100A7"], 0.028448319415720673, 0, 0], [23, "cellular response to interferon-beta (GO:0035458)", 0.0059856908667451705, 210.26315789473685, 1076.2074808846232, ["IFNB1"], 0.028448319415720673, 0, 0], [24, "regulation of granulocyte chemotaxis (GO:0071622)", 0.0059856908667451705, 210.26315789473685, 1076.2074808846232, ["S100A7"], 0.028448319415720673, 0, 0], [25, "natural killer cell activation involved in immune response (GO:0002323)", 0.006284191332539439, 199.74, 1012.6254955871668, ["IFNB1"], 0.028448319415720673, 0, 0], [26, "positive regulation of granulocyte chemotaxis (GO:0071624)", 0.006582617147928667, 190.21904761904761, 955.5316921910462, ["S100A7"], 0.028448319415720673, 0, 0], [27, "lymphocyte activation involved in immune response (GO:0002285)", 0.007179244874171303, 173.66086956521738, 857.2874884567655, ["IFNB1"], 0.028448319415720673, 0, 0], [28, "endocrine system development (GO:0035270)", 0.007179244874171303, 173.66086956521738, 857.2874884567655, ["NKX2-1"], 0.028448319415720673, 0, 0], [29, "response to dsRNA (GO:0043331)", 0.007477446810139074, 166.41666666666666, 814.7533474976135, ["IFNB1"], 0.028448319415720673, 0, 0], [30, "positive regulation of T cell migration (GO:2000406)", 0.007477446810139074, 166.41666666666666, 814.7533474976135, ["S100A7"], 0.028448319415720673, 0, 0], [31, "regulation of monocyte chemotaxis (GO:0090025)", 0.007775574144635047, 159.752, 775.8783981291459, ["S100A7"], 0.028448319415720673, 0, 0], [32, "response to interferon-beta (GO:0035456)", 0.008371605061186147, 147.9037037037037, 707.410051609059, ["IFNB1"], 0.028448319415720673, 0, 0], [33, "T cell activation involved in immune response (GO:0002286)", 0.008371605061186147, 147.9037037037037, 707.410051609059, ["IFNB1"], 0.028448319415720673, 0, 0], [34, "negative regulation of epithelial to mesenchymal transition (GO:0010719)", 0.008669508668721345, 142.61428571428573, 677.1245223853919, ["NKX2-1"], 0.028448319415720673, 0, 0], [35, "protein N-linked glycosylation via asparagine (GO:0018279)", 0.008967337727522093, 137.68965517241378, 649.0919521468393, ["ASGR2"], 0.028448319415720673, 0, 0], [36, "respiratory tube development (GO:0030323)", 0.008967337727522093, 137.68965517241378, 649.0919521468393, ["NKX2-1"], 0.028448319415720673, 0, 0], [37, "peptidyl-asparagine modification (GO:0018196)", 0.009265092249714469, 133.09333333333333, 623.0766346487915, ["ASGR2"], 0.028448319415720673, 0, 0], [38, "positive regulation of mononuclear cell migration (GO:0071677)", 0.009265092249714469, 133.09333333333333, 623.0766346487915, ["S100A7"], 0.028448319415720673, 0, 0], [39, "B cell proliferation (GO:0042100)", 0.00956277225126547, 128.79354838709676, 598.8742368950442, ["IFNB1"], 0.028448319415720673, 0, 0], [40, "respiratory system development (GO:0060541)", 0.010455365255350332, 117.41176470588235, 535.4727918518732, ["NKX2-1"], 0.028448319415720673, 0, 0], [41, "response to exogenous dsRNA (GO:0043330)", 0.010455365255350332, 117.41176470588235, 535.4727918518732, ["IFNB1"], 0.028448319415720673, 0, 0], [42, "cellular response to virus (GO:0098586)", 0.010455365255350332, 117.41176470588235, 535.4727918518732, ["IFNB1"], 0.028448319415720673, 0, 0], [43, "lung development (GO:0030324)", 0.010455365255350332, 117.41176470588235, 535.4727918518732, ["NKX2-1"], 0.028448319415720673, 0, 0], [44, "positive regulation of innate immune response (GO:0045089)", 0.010752747305294047, 114.05142857142857, 516.9488201244333, ["IFNB1"], 0.02859253260725917, 0, 0], [45, "lymphocyte proliferation (GO:0046651)", 0.011347288056139465, 107.87567567567568, 483.15104128778233, ["IFNB1"], 0.028861580490615598, 0, 0], [46, "regulation of apoptotic signaling pathway (GO:2001233)", 0.011347288056139465, 107.87567567567568, 483.15104128778233, ["IFNB1"], 0.028861580490615598, 0, 0], [47, "regulation of T cell differentiation (GO:0045580)", 0.011644446786079536, 105.03157894736842, 467.6978364624713, ["IFNB1"], 0.02898723987172991, 0, 0], [48, "keratinocyte differentiation (GO:0030216)", 0.012238541027235605, 99.77, 439.3037926149688, ["S100A7"], 0.029831443753886785, 0, 0], [49, "natural killer cell activation (GO:0030101)", 0.012832337737452553, 95.00952380952381, 413.84123997008294, ["IFNB1"], 0.03020813330976402, 0, 0], [50, "branching morphogenesis of an epithelial tube (GO:0048754)", 0.013129124551655722, 92.7953488372093, 402.07503337293304, ["NKX2-1"], 0.03020813330976402, 0, 0], [51, "negative regulation of T cell activation (GO:0050868)", 0.013425837026561787, 90.68181818181819, 390.89071422300736, ["IFNB1"], 0.03020813330976402, 0, 0], [52, "positive regulation of response to biotic stimulus (GO:0002833)", 0.013425837026561787, 90.68181818181819, 390.89071422300736, ["IFNB1"], 0.03020813330976402, 0, 0], [53, "epidermal cell differentiation (GO:0009913)", 0.015796862298306416, 76.7, 318.1473007644563, ["S100A7"], 0.03423400079254664, 0, 0], [54, "negative regulation of viral genome replication (GO:0045071)", 0.016092906355470643, 75.24905660377358, 310.73170127161313, ["IFNB1"], 0.03423400079254664, 0, 0], [55, "positive regulation of leukocyte chemotaxis (GO:0002690)", 0.016092906355470643, 75.24905660377358, 310.73170127161313, ["S100A7"], 0.03423400079254664, 0, 0], [56, "positive regulation of apoptotic signaling pathway (GO:2001235)", 0.017572013994556906, 68.7448275862069, 277.8286292162732, ["IFNB1"], 0.0360688708309326, 0, 0], [57, "response to reactive oxygen species (GO:0000302)", 0.017572013994556906, 68.7448275862069, 277.8286292162732, ["S100A7"], 0.0360688708309326, 0, 0], [58, "B cell differentiation (GO:0030183)", 0.01816313808123624, 66.44666666666667, 266.34223514766154, ["IFNB1"], 0.03627612202076156, 0, 0], [59, "regulation of innate immune response (GO:0045088)", 0.0190492685407353, 63.27301587301587, 250.60711544601855, ["IFNB1"], 0.03627612202076156, 0, 0], [60, "antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)", 0.0190492685407353, 63.27301587301587, 250.60711544601855, ["S100A7"], 0.03627612202076156, 0, 0], [61, "type I interferon signaling pathway (GO:0060337)", 0.019344497240045323, 62.28125, 245.72116030177747, ["IFNB1"], 0.03627612202076156, 0, 0], [62, "cellular response to type I interferon (GO:0071357)", 0.019344497240045323, 62.28125, 245.72116030177747, ["IFNB1"], 0.03627612202076156, 0, 0], [63, "protein N-linked glycosylation (GO:0006487)", 0.019934732540743783, 60.38787878787879, 236.43616149285907, ["ASGR2"], 0.03627612202076156, 0, 0], [64, "regulation of viral genome replication (GO:0045069)", 0.019934732540743783, 60.38787878787879, 236.43616149285907, ["IFNB1"], 0.03627612202076156, 0, 0], [65, "negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)", 0.02022973917450602, 59.483582089552236, 232.02175076653654, ["NKX2-1"], 0.03627612202076156, 0, 0], [66, "regulation of transcription by RNA polymerase II (GO:0006357)", 0.020728704660723057, 8.075805719473445, 31.303727572383085, ["EGR4", "IFNB1", "NKX2-1"], 0.03627612202076156, 0, 0], [67, "negative regulation of viral process (GO:0048525)", 0.020819530478468958, 57.7536231884058, 223.6141610659621, ["IFNB1"], 0.03627612202076156, 0, 0], [68, "gland development (GO:0048732)", 0.021114315180935466, 56.925714285714285, 219.60824963740106, ["NKX2-1"], 0.03627612202076156, 0, 0], [69, "defense response to Gram-negative bacterium (GO:0050829)", 0.02170366274746418, 55.33888888888889, 211.9631207182121, ["S100A7"], 0.03627612202076156, 0, 0], [70, "response to molecule of bacterial origin (GO:0002237)", 0.02170366274746418, 55.33888888888889, 211.9631207182121, ["S100A7"], 0.03627612202076156, 0, 0], [71, "positive regulation of immune response (GO:0050778)", 0.022292714638201434, 53.83783783783784, 204.7719659635136, ["IFNB1"], 0.036704085836694246, 0, 0], [72, "regulation of epithelial to mesenchymal transition (GO:0010717)", 0.022587129745657998, 53.117333333333335, 201.3346131407168, ["NKX2-1"], 0.036704085836694246, 0, 0], [73, "skin development (GO:0043588)", 0.023764051554239853, 50.41772151898734, 188.54116752551658, ["S100A7"], 0.03808758947734332, 0, 0], [74, "epidermis development (GO:0008544)", 0.024645967784075077, 48.56585365853658, 179.84625102158773, ["S100A7"], 0.03884637548639252, 0, 0], [75, "lymphocyte differentiation (GO:0030098)", 0.0249397922961005, 47.97831325301205, 177.10189992485337, ["IFNB1"], 0.03884637548639252, 0, 0], [76, "B cell activation (GO:0042113)", 0.02523354305099001, 47.404761904761905, 174.42966577015417, ["IFNB1"], 0.03884637548639252, 0, 0], [77, "T cell activation (GO:0042110)", 0.027287734343433324, 43.74285714285714, 157.5319374528161, ["IFNB1"], 0.04137134334218952, 0, 0], [78, "positive regulation of peptidyl-serine phosphorylation (GO:0033138)", 0.02758089556145968, 43.26521739130435, 155.34947127174277, ["IFNB1"], 0.04137134334218952, 0, 0], [79, "positive regulation of defense response (GO:0031349)", 0.02904559756492306, 41.02474226804124, 145.18198263769264, ["IFNB1"], 0.043016897659443006, 0, 0], [80, "regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)", 0.029630963394411815, 40.19191919191919, 141.432767389918, ["NKX2-1"], 0.04333528396432728, 0, 0], [81, "negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)", 0.0319694869760854, 37.17196261682243, 127.98207714314651, ["NKX2-1"], 0.046178147854345576, 0, 0], [82, "negative regulation of cell motility (GO:2000146)", 0.033720296216731616, 35.18761061946903, 119.27387298714444, ["NKX2-1"], 0.04753342960671806, 0, 0], [83, "response to lipid (GO:0033993)", 0.033720296216731616, 35.18761061946903, 119.27387298714444, ["S100A7"], 0.04753342960671806, 0, 0], [84, "defense response to symbiont (GO:0140546)", 0.036632447786472476, 32.31056910569106, 106.84526455648567, ["IFNB1"], 0.05102376655972952, 0, 0], [85, "defense response to virus (GO:0051607)", 0.03924712768834303, 30.093939393939394, 97.44047472504964, ["IFNB1"], 0.054022516935719224, 0, 0], [86, "positive regulation of response to external stimulus (GO:0032103)", 0.040986960225553155, 28.776811594202897, 91.92756222432686, ["IFNB1"], 0.05576132960918278, 0, 0], [87, "negative regulation of cell migration (GO:0030336)", 0.042434814389666786, 27.763636363636362, 87.72715392092086, ["NKX2-1"], 0.05706750900679326, 0, 0], [88, "brain development (GO:0007420)", 0.04416983459325144, 26.63758389261745, 83.1016220368009, ["NKX2-1"], 0.05872580281148203, 0, 0], [89, "response to lipopolysaccharide (GO:0032496)", 0.046767452580978475, 25.10886075949367, 76.89758784588065, ["S100A7"], 0.061480808449151485, 0, 0], [90, "positive regulation of ERK1 and ERK2 cascade (GO:0070374)", 0.050509180130790456, 23.184795321637427, 69.2205289569504, ["S100A7"], 0.0656619341700276, 0, 0], [91, "defense response to bacterium (GO:0042742)", 0.05165801551321664, 22.650285714285715, 67.11528598348353, ["S100A7"], 0.06641744851699283, 0, 0], [92, "negative regulation of cell differentiation (GO:0045596)", 0.05595583741739159, 20.846315789473685, 60.10394168947767, ["NKX2-1"], 0.07116122801994365, 0, 0], [93, "negative regulation of multicellular organismal process (GO:0051241)", 0.06251430040361035, 18.573708920187794, 51.49300658384643, ["NKX2-1"], 0.07864702308841302, 0, 0], [94, "regulation of ERK1 and ERK2 cascade (GO:0070372)", 0.06931738938855214, 16.672573839662448, 44.500091181655506, ["S100A7"], 0.08627802721766598, 0, 0], [95, "positive regulation of signal transduction (GO:0009967)", 0.07326682369290423, 15.731474103585658, 41.11652611319615, ["IFNB1"], 0.09023387760073469, 0, 0], [96, "central nervous system development (GO:0007417)", 0.07776335159216254, 14.776779026217229, 37.74114992527251, ["NKX2-1"], 0.09477408475294809, 0, 0], [97, "positive regulation of MAPK cascade (GO:0043410)", 0.07944485535766266, 14.447619047619048, 36.59137122245166, ["S100A7"], 0.09582523790563434, 0, 0], [98, "innate immune response (GO:0045087)", 0.0872581320254043, 13.085049833887043, 31.9129254638413, ["S100A7"], 0.10417552496910515, 0, 0], [99, "positive regulation of apoptotic process (GO:0043065)", 0.08948031840285002, 12.741100323624595, 30.753659971516722, ["IFNB1"], 0.10574946720336821, 0, 0], [100, "positive regulation of macromolecule metabolic process (GO:0010604)", 0.10982267971767223, 10.240731070496084, 22.620630189252047, ["NKX2-1"], 0.1284925352696765, 0, 0], [101, "regulation of cell migration (GO:0030334)", 0.11633828630365514, 9.625061425061425, 20.70594294612794, ["NKX2-1"], 0.13476811383690743, 0, 0], [102, "negative regulation of nucleic acid-templated transcription (GO:1903507)", 0.13138696365173613, 8.436717062634989, 17.12323172617443, ["NKX2-1"], 0.1492289500399958, 0, 0], [103, "positive regulation of cell population proliferation (GO:0008284)", 0.13405161943292423, 8.254122621564482, 16.586909784962376, ["EGR4"], 0.1492289500399958, 0, 0], [104, "neutrophil degranulation (GO:0043312)", 0.13591282245621636, 8.130833333333333, 16.22704240839014, ["S100A7"], 0.1492289500399958, 0, 0], [105, "positive regulation of gene expression (GO:0010628)", 0.13617843625530518, 8.113513513513514, 16.176635795129393, ["NKX2-1"], 0.1492289500399958, 0, 0], [106, "cellular response to cytokine stimulus (GO:0071345)", 0.13617843625530518, 8.113513513513514, 16.176635795129393, ["IFNB1"], 0.1492289500399958, 0, 0], [107, "neutrophil activation involved in immune response (GO:0002283)", 0.13697486946968407, 8.061983471074381, 16.026882961137105, ["S100A7"], 0.1492289500399958, 0, 0], [108, "neutrophil mediated immunity (GO:0002446)", 0.13777069069054648, 8.011088295687886, 15.879295928232638, ["S100A7"], 0.1492289500399958, 0, 0], [109, "regulation of transcription, DNA-templated (GO:0006355)", 0.13902526114837216, 3.958965209634255, 7.811432780346923, ["EGR4", "NKX2-1"], 0.1492289500399958, 0, 0], [110, "positive regulation of nucleic acid-templated transcription (GO:1903508)", 0.14385169452323945, 7.64078431372549, 14.815269969426804, ["NKX2-1"], 0.15300589326562744, 0, 0], [111, "negative regulation of cellular macromolecule biosynthetic process (GO:2000113)", 0.15329801811567262, 7.123809523809523, 13.359788791957792, ["NKX2-1"], 0.16158439747327652, 0, 0], [112, "cytokine-mediated signaling pathway (GO:0019221)", 0.17244290587638317, 6.249677419354839, 10.984989739295798, ["IFNB1"], 0.1796078382353798, 0, 0], [113, "positive regulation of cellular process (GO:0048522)", 0.1734673993213497, 6.208333333333333, 10.875544750623106, ["EGR4"], 0.1796078382353798, 0, 0], [114, "negative regulation of transcription by RNA polymerase II (GO:0000122)", 0.18845634920732277, 5.654758418740849, 9.437163376844246, ["NKX2-1"], 0.1934157268180418, 0, 0], [115, "regulation of cell population proliferation (GO:0042127)", 0.20841797228460673, 5.04089121887287, 7.905174674708202, ["EGR4"], 0.21204263267216508, 0, 0], [116, "negative regulation of transcription, DNA-templated (GO:0045892)", 0.25278167769899834, 4.02259767687434, 5.531993369927694, ["NKX2-1"], 0.2549608300929552, 0, 0], [117, "regulation of gene expression (GO:0010468)", 0.2830873472213558, 3.5094619666048237, 4.4289402351621945, ["NKX2-1"], 0.2830873472213558, 0, 0]], [[1, "regulation of growth rate (GO:0040009)", 0.00224816055240216, 624.59375, 3808.549663430724, ["TMPRSS4"], 0.047164363128863705, 0, 0], [2, "sialic acid transport (GO:0015739)", 0.00224816055240216, 624.59375, 3808.549663430724, ["SLC17A4"], 0.047164363128863705, 0, 0], [3, "positive regulation of viral entry into host cell (GO:0046598)", 0.004491844107510829, 277.52777777777777, 1500.1741678966396, ["TMPRSS4"], 0.047164363128863705, 0, 0], [4, "positive regulation by symbiont of entry into host (GO:0075294)", 0.004491844107510829, 277.52777777777777, 1500.1741678966396, ["TMPRSS4"], 0.047164363128863705, 0, 0], [5, "positive regulation of viral life cycle (GO:1903902)", 0.010750337464808102, 108.52173913043478, 491.90930693624915, ["TMPRSS4"], 0.06375157330727682, 0, 0], [6, "positive regulation of leukocyte cell-cell adhesion (GO:1903039)", 0.013866454289070039, 83.17083333333333, 355.82833874131705, ["SIRPG"], 0.06375157330727682, 0, 0], [7, "positive regulation of lymphocyte activation (GO:0051251)", 0.015643173290839224, 73.37132352941177, 305.0574683216414, ["SIRPG"], 0.06375157330727682, 0, 0], [8, "regulation of viral entry into host cell (GO:0046596)", 0.017417046832985512, 65.63486842105263, 265.8412914846341, ["TMPRSS4"], 0.06375157330727682, 0, 0], [9, "regulation of cell-cell adhesion (GO:0022407)", 0.01918807882344009, 59.37202380952381, 234.72528267100722, ["SIRPG"], 0.06375157330727682, 0, 0], [10, "anion transport (GO:0006820)", 0.01918807882344009, 59.37202380952381, 234.72528267100722, ["SLC17A4"], 0.06375157330727682, 0, 0], [11, "positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862)", 0.02095627318649442, 54.19836956521739, 209.49389233222107, ["BMP3"], 0.06375157330727682, 0, 0], [12, "regulation of T cell activation (GO:0050863)", 0.02095627318649442, 54.19836956521739, 209.49389233222107, ["SIRPG"], 0.06375157330727682, 0, 0], [13, "positive regulation of cell-cell adhesion (GO:0022409)", 0.02095627318649442, 54.19836956521739, 209.49389233222107, ["SIRPG"], 0.06375157330727682, 0, 0], [14, "positive regulation of phagocytosis (GO:0050766)", 0.023603252767760232, 47.93028846153846, 179.56463060223416, ["SIRPG"], 0.06375157330727682, 0, 0], [15, "carboxylic acid transport (GO:0046942)", 0.025364370254955197, 44.497767857142854, 163.5030358762894, ["SLC17A4"], 0.06375157330727682, 0, 0], [16, "regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393)", 0.02580420824342157, 43.71491228070175, 159.87495051613905, ["BMP3"], 0.06375157330727682, 0, 0], [17, "regulation of phagocytosis (GO:0050764)", 0.02580420824342157, 43.71491228070175, 159.87495051613905, ["SIRPG"], 0.06375157330727682, 0, 0], [18, "positive regulation of T cell activation (GO:0050870)", 0.03325451045778232, 33.64358108108108, 114.5081106084989, ["SIRPG"], 0.07759385773482542, 0, 0], [19, "positive regulation of cell adhesion (GO:0045785)", 0.03543611612294145, 31.50632911392405, 105.23188749884586, ["SIRPG"], 0.07761242296639746, 0, 0], [20, "sodium ion transport (GO:0006814)", 0.039786204244047274, 27.952247191011235, 90.12461522615385, ["SLC17A4"], 0.07761242296639746, 0, 0], [21, "positive regulation of transport (GO:0051050)", 0.04022025247919156, 27.64027777777778, 88.81884342634399, ["SIRPG"], 0.07761242296639746, 0, 0], [22, "positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100)", 0.040654126315732, 27.335164835164836, 87.54510068843584, ["BMP3"], 0.07761242296639746, 0, 0], [23, "protein maturation (GO:0051604)", 0.04282088157064431, 25.904947916666668, 81.61948121913939, ["TMPRSS4"], 0.07819465330291568, 0, 0], [24, "protein processing (GO:0016485)", 0.046710081786484385, 23.673809523809524, 72.5317052519737, ["TMPRSS4"], 0.08174264312634767, 0, 0], [25, "ion transport (GO:0006811)", 0.051014935889860884, 21.604347826086958, 64.2866930480565, ["SLC17A4"], 0.08570509229496628, 0, 0], [26, "negative regulation of growth (GO:0045926)", 0.05530250201455211, 19.866, 57.51082096679438, ["TMPRSS4"], 0.08933481094658419, 0, 0], [27, "enzyme linked receptor protein signaling pathway (GO:0007167)", 0.06127616634057289, 17.85251798561151, 49.85073415990269, ["ANGPTL1"], 0.09531848097422449, 0, 0], [28, "skeletal system development (GO:0001501)", 0.06890724443039566, 15.79140127388535, 42.24190306488084, ["BMP3"], 0.10336086664559349, 0, 0], [29, "cation transport (GO:0006812)", 0.07564408105928605, 14.31936416184971, 36.968532753958556, ["SLC17A4"], 0.1095534967065522, 0, 0], [30, "regulation of macromolecule metabolic process (GO:0060255)", 0.08649906605727922, 12.4321608040201, 30.429226090981548, ["TMPRSS4"], 0.12109869248019091, 0, 0], [31, "phosphate-containing compound metabolic process (GO:0006796)", 0.0914707296716085, 11.718009478672986, 28.02638807349727, ["SLC17A4"], 0.1239280853615341, 0, 0], [32, "proteolysis (GO:0006508)", 0.12200241335360172, 8.612325174825175, 18.117872942989372, ["TMPRSS4"], 0.16012816752660225, 0, 0], [33, "positive regulation of protein phosphorylation (GO:0001934)", 0.1551122195058613, 6.628716216216216, 12.353318144692642, ["BMP3"], 0.19543203004367343, 0, 0], [34, "negative regulation of cell population proliferation (GO:0008285)", 0.1582068814639261, 6.485780423280423, 11.958817428486013, ["SIRPG"], 0.19543203004367343, 0, 0], [35, "transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)", 0.16781286387234287, 6.075682382133995, 10.844520880520044, ["ANGPTL1"], 0.20137543664681143, 0, 0], [36, "positive regulation of cell population proliferation (GO:0008284)", 0.19419335631720047, 5.158033826638478, 8.453506457263389, ["SIRPG"], 0.22655891570340056, 0, 0], [37, "negative regulation of cellular process (GO:0048523)", 0.22773331955334702, 4.297787610619469, 6.358920531398367, ["SIRPG"], 0.25850809246596146, 0, 0], [38, "positive regulation of cellular process (GO:0048522)", 0.24858393121402697, 3.879607371794872, 5.400315459189092, ["SIRPG"], 0.27475066081550353, 0, 0], [39, "regulation of cell population proliferation (GO:0042127)", 0.29574133486516935, 3.1500655307994756, 3.8376305717304233, ["SIRPG"], 0.3184906683163362, 0, 0], [40, "regulation of gene expression (GO:0010468)", 0.3930084885087277, 2.19306586270872, 2.048156992084284, ["TMPRSS4"], 0.4126589129341641, 0, 0], [41, "regulation of transcription by RNA polymerase II (GO:0006357)", 0.6507822338118429, 1.0082766439909296, 0.4331356854141271, ["ONECUT3"], 0.657438598129094, 0, 0], [42, "regulation of transcription, DNA-templated (GO:0006355)", 0.657438598129094, 0.9890771288452965, 0.414822811338105, ["ONECUT3"], 0.657438598129094, 0, 0]]]}